




UNIVERSITÀ DEGLI STUDI DI SASSARI 
CORSO DI DOTTORATO DI RICERCA IN SCIENZE BIOMEDICHE 
Coordinatore del Corso: Prof. Andrea Fausto Piana 
CURRICULUM IN NEUROSCIENZE 





Peripheral neuromodulation for drug-resistant 
epilepsy: the effect of short-term transcutaneous 








 Prof. GianPietro Sechi 
 Prof.ssa Franca Deriu 
 
 
    Tesi di dottorato di: 
    Dott.ssa Chiara Fois 






FIRST SECTION: Introduction 
1. DRUG-RESISTANT EPILEPSY 
1.1 Definition and epidemiology 
1.2 Mechanisms of refractoriness 
2. NEUROSTIMULATION IN EPILEPSY 
2.1 Peripheral neurostimulation devices 
2.1.1 Vagal nerve stimulation (VNS) 
2.1.1.1 Mechanisms of action 
2.1.1.2 Clinical indications and efficacy 
2.1.1.3 Adverse effects 
2.1.2 Trigeminal nerve stimulation (TNS) 
2.1.2.1 Mechanisms of action  
2.1.2.2 Clinical indications and efficacy 
2.1.2.3 Adverse effects 
3. EFFECT OF PERIPHERAL NEUROSTIMULATION ON EEG 
BACKGROUND ACTIVITY: STATE OF THE ART 
3.1 VNS 
3.1.1 Epileptiform activity changes 
3.1.2 Quantitative EEG analysis 
3.2 TNS 
3.2.1 Epileptiform activity changes 





SECOND SECTION: clinical study  
1. BACKGROUND AND AIMS 
2. MATERIALS AND METHODS 
2.1 Subjects 
2.2 TNS protocol 
2.3 EEG recording  
2.3.1 Qualitative analysis (IEDs detection) 
2.3.2 Quantitative analysis (power spectra) 
2.4 Statistical analysis 
3. RESULTS 
3.1 Demographics 
3.2 IEDs detection  
3.3 Spectral analysis 
 
DISCUSSION AND CONCLUSION 














Aim: Trigeminal nerve stimulation (TNS) has been proven to exert beneficial effects on 
symptoms of drug-resistant epilepsy (DRE). However, whether and how TNS is able to 
modulate the electroencephalogram (EEG) background activity in DRE patients is still 
unknown. We aimed to investigate the effect of acute TNS on EEG activity by 
conducting qualitative (morphologic) and quantitative (power spectra) analyses on two 
groups of DRE patients, undergoing real or sham TNS.  
Methods: Twenty-two DRE patients were randomly divided into a “sham-TNS” or 
“real-TNS” group. Real-TNS was delivered bilaterally to the infraorbital nerve with 
trains of a symmetric biphasic square wave pulse (1 to 20 mA, 120 Hz), in a cyclic 
modality for 20 minutes. The sham-TNS protocol mimicked the real-TNS stimulation 
but at a zero intensity. EEG recordings were collected for each patient 10 minutes pre, 
20 minutes during and 10 minutes post TNS delivery. EEG signal was subsequently 
visually analysed for interictal epileptiform discharge (IEDs) and processed by spectral 
analysis (Fast Fourier Transform). A between and within subject repeated-measures 
ANOVA was used for statistical analyses.  
Results: A significant increase of EEG absolute alpha power was observed in the 
during real-TNS compared to the sham-TNS (F2,18=1.748; p=0.006). Conversely, no 
significant effects were noticed either for quantitative analysis of other frequency bands 
or for IEDs detection.  
Conclusion: Short-term TNS is able to induce an acute effect on EEG background 
composition of DRE patients. In line with recent evidence, alpha rhythm enhancement 
might be interpreted as an index of functional inhibition, able to influence cortical 
activity and thus reduce seizure propensity. 
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1. DRUG-RESISTANT EPILEPSY 
1.1 Definition and epidemiology 
The International League Against Epilepsy (ILAE) Task Force defined Epilepsy as 
“an enduring predisposition to generate epileptic seizures and by the neurobiologic, 
cognitive, psychological and social consequences of this condition” (Fisher et al., 
2005, 2014). 
Epilepsy is one of the most common disorders of the brain, affecting worldwide 50 
million people of all ages. According to the World Health Organization (WHO) 
survey, it accounts for 1% of the global burden of disease, higher than Alzheimer’s 
disease, multiple sclerosis and Parkinson’s disease combined and similar to breast 
cancer in women and lung cancer in men, with an estimated prevalence of active 
forms (i.e. continuing seizures or with the need for treatment) between 4 and 10 per 
1000 people and 2.4 million of new epilepsy diagnoses each year (Murray and Lopez, 
1994; Murray et al., 2012). 
Ideal goals for epilepsy treatment would be achieving complete seizure control while 
avoiding drug side effects, in order to improve quality of life and reduce disability and 
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morbidity. Up to 70% of epileptic patients can be successfully and completely treated 
with first line therapy, consisting in daily medication with one or more anti-epileptic 
drugs (AEDs) with a global cost of US$ 5 per year (Kwan and Brodie, 2000; World 
Health Organization atlas, 2005). After 2-year therapy, more than a half of patients 
can continue to be seizure free following drug discontinuation (Specchio and Beghi, 
2004; Strozzi et al., 2015).   
However, approximately one-third of epilepsy patients (i.e. 1 million people in the 
United States) despite adequate pharmacotherapy, continues to suffer from 
uncontrolled seizures (Kobau et al., 2008; Kwan and Brodie, 2000). This medically 
refractory condition represents the greatest burden of the disease and accounts for the 
80% of the cost of epilepsy (Begley et al., 2000). It is generally termed “pharmaco-
resistant”, “medically intractable” or “drug-resistant” epilepsy (DRE) and has been 
recently defined by the ILAE task force as “the failure of adequate trials of two 
tolerated and appropriately chosen and used AED schedules (whether as 
monotherapies or in combination) to achieve sustained seizure freedom” (Kwan et al., 
2010). 
Besides the risks of frequent life-threatening seizures, which increase mortality rate to 
5–10 times of the general population, DRE appears associated with developmental 
delay, severe lifetime disability and morbidity in all ages (Lhatoo and Sander, 2001; 
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Sperling et al., 2016). Uncontrolled seizures may cause progressive cognitive 
impairment, eventually resulting in family dependence or institutionalization, with 
important social and financial burdens. Furthermore, psychological morbidities (such 
as depression, behavioural disturbances, anxiety and memory loss) may contribute to 
the risk of physical injuries (Bell et al., 2008; Hermann et al., 2006; Sheth et al., 
2004), sudden unexpected death (SUDEP) (Langan et al., 2005; Walczak et al., 2001) 
and diminished health-related quality of life (Jacoby and Baker, 2008). 
In order to early identify and prevent the causes of pharmaco-resistance, some studies 
focused on predictive factors of poor drug-responsiveness outcome, including the 
patient’s history, the timing of AED response and the epilepsy/seizure features.  
In particular, aetiology of epilepsy seems to be an important risk factor for DRE 
development. While childhood and adolescence idiopathic epilepsies (without 
structural brain damage and with hereditary predisposition) are generally less likely to 
become drug resistant (13%), symptomatic epilepsy (associated with structural brain 
lesions or epileptic encephalopathies) tends to be more AED-resistant (Sillanpaa et al., 
1999). In general, epileptic encephalopathies such as Ohtahara syndrome, early 
myoclonic encephalopathy, West syndrome, Dravet syndrome and Lennox-Gastaut 
syndrome carry more than 50% of chance to become medical refractory (Mohamed 
and Minassian, 2006; Camfield and Camfield, 2003; Berg et al., 2006); whereas 
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symptomatic focal epilepsies, such as those secondary to structural brain lesions or 
malformations (hippocampal sclerosis, cortical dysplasia, brain injuries, haemorrhage, 
tumors, etc.) are at higher risk (65%) than cryptogenic forms (55%) (Briggs and 
French, 2003; Semah et al., 1998). 
Other important predictors of DRE seem a high frequency of seizures prior to 
treatment (Elwes et al., 1984; Sillanpaa et al., 1993, 2009; Kwan and Brodie, 2000; 
Berg et al., 2001; Hitiris et al., 2007), age at onset (Ko TS and Holmes, 1999) and 
family history of epilepsy (Hitiris et al., 2007), a personal history of infantile spasms, 
neonatal or febrile seizures or status epilepticus and presence of neurological 
impairments (Berg et al., 1996, 2001; Oskoui et al., 2005).  
While the epileptogenic zone (in particular the temporal lobe and sensorimotor 
cortices localization) seems to play a role in refractoriness mechanisms, inconsistent 
are data regarding seizure types and electroencephalogram findings, which did not 
show a clear-cut prognostic value (Mohanraj and Brodie, 2013).  
Importantly, inadequate response to the first AED therapy has been shown to be the 
most powerful indicator of refractory epilepsy (Mohanraj and Brodie, 2013; Kwan and 
Brodie, 2000). Generally, seizure-free rates decrease from 61.8% for the first AED to 
41.7% after the second AED and to 16.6% after 2–5 subsequent inefficient trials. 
After 6 AEDs, absolute refractoriness (0% seizure free) is very likely (Schiller and 
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Najjar, 2008). Overall, patients who do not respond to the first two AEDs trials have 
only a small percentage chance to become seizure-free with any additional AED. 
Therefore, having ruled out pseudo-pharmacoresistance imitators (such as drug 
intolerance or inadequacy, psychogenic seizures or inadequate compliance) and DRE 
has been proven, an alternative therapeutic approach is required as soon as possible. 
At this point, management of DRE may direct towards two different strategies: 
epilepsy surgery and alternative treatments including neurostimulation, ketogenic diet, 
and lifestyle changes. 
The American Academy of Neurology (AAN) Epilepsy Quality Measurement and the 
ILAE’s subcommission on pediatric epilepsy surgery recommend that all patients who 
continue to be compromised by seizures after the failure of 2 appropriate AED trials, 
deserve a consultation at a specialized, full-service Epilepsy Center (Fountain et al., 
2015; Cross et al., 2006).  
For patients suitable for curative epilepsy surgery, in particular for those with distinct 
resectable lesions, epilepsy surgery has been shown to be superior to the continued use 
of AEDs (Kwan and Brodie, 2006). However, whilst epilepsy surgery may not be 
reserved to all DRE patients, since some of them may be considered not good surgical 
candidates (such as cryptogenic epilepsies with negative brain imaging, multifocal 
epilepsies or genetic syndromes) (Fois et al., 2015), this procedure cannot guarantee 
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100% outcome in terms of seizure freedom even in the most suitable candidates (de 
Tisi et al., 2011).   
In this regard come into play alternative treatment approaches principally direct to 
reduce seizure severity and improve quality of life, such as neurostimulation methods.   
A number of peripheral (extracranial) or central (intracranial) neuromodulation 
devices have been developed over the past few decades. Some of them have obtained 
US Food and Drug Administration (FDA) and/or European Conformity (CE) 
approval, such as vagal nerve stimulation (VNS), responsive nerve stimulation (RNS), 
deep brain stimulation (DBS) and external trigeminal nerve stimulation (TNS) and 
have been used since then, showing to be efficacy additional treatments for seizure 
control (Krishna et al., 2016; DeGiorgio and Krahl, 2013b). However, some of these 
neurostimulation methods imply invasive implantation, thus carrying the risk of 
surgical procedure and leading to a series of adverse effects which can limit or 
discontinue their use (Ben-Menachem et al., 2015). 
Ketogenic diet is essentially used in children with refractory epilepsy and although 
some studies showed a high efficacy rate (Neal et al., 2008), it is challenging to 
administer and not devoid to side effects.  
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Lifestyle changes consists in avoiding seizure triggers and precipitants, such a sleep 
deprivation, psychophysical stress, alcohol intake, drugs of abuse and any potential 
photic stimulation.  
 
1.2 Mechanisms of refractoriness 
The importance to understand mechanisms underlying DRE is essentially to prevent 
and/or to treat it at an early stage of appearance.  
There are a number of theories about mechanisms of drug refractoriness, but so far 
none of them has been proven to be certain and unique. What appears instead clearer 
is that mechanisms of DRE are rather multifactorial, involving genetic inheritance, 
environmental factors and disease or drug-related features.  
Among a number of drug refractory theories, two represent the most reliable theories 
so far: (1) the transporter hypothesis and (2) the target hypothesis (Tang et al., 2017; 
Rogawski et al., 2013).  
The transporter hypothesis proposes that increased expression or function of drug 
efflux transporters, such as P-glycoprotein (P-gp) and multidrug resistance–associated 
proteins (MRPs), reduces the local concentration of AEDs in epileptic brain regions to 
a sub-therapeutic level (Loscher and Potschka, 2002).  
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The best known efflux transporters are members of the ABC (ATP-binding cassette) 
family, specifically P-gp (ABCB1 or MDR1), the MRPs (MRP1, ABCC1; MRP2, 
ABCC2) and breast cancer resistance protein (BCRP, ABCG2) (Sisodiya et al., 2006). 
These ABC transmembrane proteins cause drug-resistance while actively extruding 
substrates (i.e. therapeutic drugs) out from the cell and limiting their entry into the 
target organs.  
Multidrug resistance due to efflux transporters has been first studied in tumor cells, 
where ABC protein overexpression has been shown to induce chemotherapeutic drug 
resistance and determine a poor prognosis (Mao and Unadkat, 2015).  
In this regard, P-gp is the most studied ABC protein. It is normally expressed in 
capillary endothelial cells in the brain with the function to actively extrude xenobiotics 
from intracellular space and so to reduce their cerebral accumulation.  
In surgically treated DRE patients, blood-brain barrier and/or glial and neuronal cells 
P-gp up-regulation have been found in brain resected tissue (Sisodiya et al., 2002; 
Aronica et al., 2003). It is postulated that aberrant P-gp brain overexpression may 
cause AED resistance in a way similar to what seen for cancer patients, with active 
extrusion of some AEDs form the target brain tissue (Loscher and Potschka, 2002).  
In animal models an up-regulation of P-gp has been found following seizures and 
associated to a reduce AED brain concentration level (Tishler et al., 1995; Sisodiya et 
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al., 2002). However, human studies did not reach the same level of evidence as for 
animals and whether human P-gp is actually able to bind and extrude AEDs to a 
significant extent and whether this has clinically relevant effects on AED 
concentration and efficacy in epilepsy patients remains unclear (Tang et al., 2017; 
Rogawski et al., 2013).  
The target hypothesis postulates that alterations in the properties, function or structure 
of AED targets, such as ion channels and neurotransmitter receptors, result in 
decreased sensitivity to a drug and leads to treatment refractoriness (Remy et al., 
2003, 2006).  
According to this theory, two mechanisms of refractoriness can be advanced: the 
genetic (or intrinsic) form, where the cause of drug-interaction dysfunction has to be 
found in the inheritance predisposition to drug resistance and the acquired form, 
which is due to structural target changes secondary to enduring epileptic activity 
within the affected brain tissue.  
For instance, polymorphisms of the SCN2A gene, which encodes the α2 subunit of the 
neuronal Nav1.1 sodium channels, were found to be associated with resistance to 
antiepileptic drugs in particular to Carbamazepine and Phenytoin (Tate et al., 2005).  
Contrariwise, an altered expression and/or a reduced drug-sensitivity of subtypes of 
the γ-aminobutyric acid type A (GABAa) receptor and of the Carbamazepine binding 
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voltage-gated sodium channels have been reported in the pilocarpine model of 
epilepsy (Jandova et al., 2006; Remy et al., 2003) and found in resected brain tissue of 
drug-resistant temporal lobe epilepsy patients (Loup et al., 2000). These seizure-
induced structural or sensitivity molecular changes might be similar to what seen 
during prolonged status epilepticus, where resistance to benzodiazepines results to a 
cellular internalization of synaptic GABAa receptors (Wasterlain and  Chen, 2008; 
Fritsch et al., 2010; Joshi and Kapur, 2012). 
Besides them, other two DRE theories deserve to be mentioned: the neural network 
hypothesis which states that seizure-induced remodelling of the neural network, 
together with the formation of new excitatory circuits, suppress endogenous anti-
seizure mechanisms (Fang et al., 2011) and the intrinsic severity hypothesis which 
postulates that pharmaco-resistance is an inherent features of some type of epilepsies, 
particularly related to the severity grade of the disease and in particular to the high 
frequency of pre-treatment seizures (Rogawski 2008, 2013).  
At present, all the theories above appear still controversial and difficult to validate 
being lacking in strong evidence and reproducibility for different specific drugs, 
patients and types of epilepsy.  
Therefore, an important aim to improve epilepsy prognosis, in terms of morbidity and 
related mortality, would be the development of new therapeutic strategies targeting 
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intrinsic, neurobiological or acquired mechanisms underlying DRE and different to 
currently AED approach. Hopefully, such treatment would be able to interfere with 
aberrant neuronal network and restore the unbalance between excitatory and inhibitory 
mechanisms involved in seizure generation and propagation (Rocha, 2013). 
Several non-pharmacological strategies are also currently under consideration as 
adjunctive treatment for DRE, such as neuromodulation approaches which have 
gained much attention over the past few decades, showing promising results in terms 
of seizure reduction efficacy and safety (Dalkilic, 2017; Krishna et al., 2016; 
DeGiorgio and Krahl, 2013b). 
 
2. NEUROSTIMULATION IN EPILEPSY 
 
2.1 Peripheral neurostimuation devices 
Neurostimulation has emerged as a potential treatment option for patient with DRE who 
are not suitable for curative epilepsy surgery or continue to suffer from seizures despite 
previous inefficient surgical treatment.  
The aims of these therapeutic methods are different from those of surgery, having as the 
main target the reduction of seizure frequency or generalization and so the improvement 
12 
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of quality of life. They are also called palliative procedure since they have been 
conceived without curative intention.  
The mechanism of action of neurostimulation devices, although apparently different 
from AEDs, has not been entirely clarified since now but they have been supposed to 
modulate cortical excitability through the stimulation of subcortical structures 
(Fanselow, 2012).  
At present the neuromodulation modalities approved by FDA and/or CE for DRE 
treatment are anterior nucleus deep brain stimulation (AN-DBS), responsive 
neurostimulation (RNS), vagal nerve stimulation (VNS) and trigeminal nerve 
stimulation (TNS). Whereas the first two modalities provide central (intracranial) 
stimulation of brain structures and implantation requires very precise localization of 
seizure foci or site of stimulation, VNS and TNS represent the two different peripheral 
(extracranial) approaches for DRE treatment, able to influence the brain activity without 
carrying the invasiveness of intracranial surgery.  
The relative lack of systemic side effects, pharmacokinetic interactions, compliance 
problems and teratogenicity, together with the potential of on-demand use for 
immediate intervention during an ongoing seizure, would make peripheral 
neurostimulation devices use, advantageous compared to the addition of yet another 
AED (Schulze-Bonhage, 2017).  
13 
 
Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.    
 
2.1.1 Vagal nerve stimulation (VNS) 
Among peripheral neurostimulation devices, VNS is the one who received, in addition 
to CE marking, FDA approval in 1997 as adjunctive treatment for partial-onset 
seizures in DRE patients >12 years (The Vagus Nerve Stimulation Study Group, 1995; 
Handforth et al., 1998) and it has been proved, since then, in more than 40,000 cases 
of DRE throughout the world (Amar et al., 2000).  
The stimulation device (Cyberonics Inc, Houston, TX, USA) is similar to a cardiac 
pacemaker and it is implanted, under local or general anaesthesia, under the left 
clavicle. Two helical electrodes are wrapped around the left vagus nerve which is 
accessed in the midcervical portion of the neck between the carotid artery and the 
jugular vein and a delicate surrounding network of small vessels (DeGiorgio and 
Krahl, 2013b; Ben-Menachem, 2002; Ekmekçi and Kaptan, 2017). The right nerve is 
generally not used for risks of bradycardia or arrhythmias (Randall and Ardell, 1985). 
The stimulation has given in open loop cyclic modality with a starting level of 
stimulation of 0.25 mA (gradually increased up to 1.25–2.00 mA over several weeks); 
20–30 Hz; pulse width 250–500 μs; 30 s ON, and 5min OFF. The patient may activate 
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Recently, a non-invasive self-administrable external device which provides 
transcutaneous VNS (tVNS) by an intra-auricular electrode, received European Union 
(CE mark) approval for the epilepsy treatment; however a recent prospective 
multicenter trial, comparing 25 Hz versus 1 Hz stimulation, failed to show superiority 
of tVNS in the treatment group (high stimulation) compared to the sham group (low 
stimulation) (Bauer et al., 2016). Further, Cyberonics developed a closed-loop VNS 
device which incorporates a closed-loop system that detects heart rate increase that 
may be associated with seizure events and delivers stimulation automatically. 
 
2.1.1.1 Mechanisms of action 
The vagus (X cranial) nerve is a mixed parasympathetic nerve, containing both afferent 
and efferent sensory fibers. An estimated 80% of vagus nerve fibers are afferent and 
convey visceral, somatic and taste sensations. The efferent tracts innervate striated 
muscle of the larynx and parasympathetic projections for the heart, lungs, and 
gastrointestinal tract (Rutecki, 1990). Vagus nerve provides an asymmetrical heart 
innervation which explains why VNS implants are placed on the left side of the neck 
(atrioventricular node innervation) and not the right side (sinoatrial node innervation). 
15 
 
Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.    
 
The nerve is essentially composed of A- large myelinated fibers and C- small 
unmyelinated fibers, which carry afferent visceral information to the brain, and B- small 
myelinated fibers for parasympathetic efferent signals (Foley and DuBois, 1937). 
Multiple studies have demonstrated that the mechanism of VNS is essentially mediated 
by central responses to activation of afferent fibers rather than peripheral projections 
(Zabara, 1992; Osharina et al., 2006). 
What has been largely debated is whether only A and B myelinated fibres or also C 
afferent fibres are needed for the antiepileptic effect of VNS. Evidence against the C 
fiber theory is the lack of significant effect on pain sensation, heart rate or blood 
pressure or other autonomic functions after VNS (Banzett et al., 1999; Lotvall et al., 
1994) and evidence that selective capsaicin-induced destruction of these small 
unmyelinated fibers in rats, does not alter VNS antiepileptic effects (Krahl et al., 2001).  
The clinical importance of these experimental data consists on the lower amount of 
current necessary to produce the antiepileptic effects of VNS, since A- and B-fibers 
have a much lower activation threshold as compared to C-fibers, which permit to avoid 
side effects from requiring higher current or longer pulses stimulation parameters (Krahl 
and Clark, 2012).  
The afferent fibres project to the nucleus tractus solitarius (NTS), the dorsal motor 
nucleus, area postrema, medial reticular formation and the nucleus cunneatus. NTS in 
16 
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turn, connects with higher centres in the brain such as the hypothalamus, dorsal raphe, 
nucleus ambigus, dorsal motor nucleus of the vagus nerve, amygdala and thalamus, 
which in turn projects to the insular cortex (Cheng et al., 2004). Moreover, NTS also 
projects both directly and indirectly to monoamine nuclei in the brainstem, the locus 
coeruleus (LC) and the raphe nuclei (RN) (Krahl and Clark, 2012). 
Because of its extensive connection with multiple sites of potential seizure genesis 
throughout the brain, NTS is hypothesized as a central mediator of VNS action 
(Beekwilder and Beems, 2010).  
Increasing evidence suggested that noradrenergic and serotonergic neurons may exert 
antiepileptic effects in a wide variety of seizure models (Krahl and Clark, 2012) and that 
LC and RN may mediate the major effect of VNS, as bilateral chemical lesions of these 
centers abolish the antiepileptic effect of VNS therapy (Krahl et al., 1998; Fornai et al., 
2011). 
Furthermore, recent studies showed that VNS increased the basal firing rates of LC 
neurons as well as their propensity to fire in bursts of action potentials (Groves et al., 
2005). This support previous finding in rat models treated with VNS, which showed an 
induced c-fos expression in the LC as an index of recent increase in local neuronal 
activity (Naritoku et al., 1995).  
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Norepinephrine and serotonin have been further shown to induce GABA interneuron 
releasing in the brain, and it has been also previously demonstrated that VNS causes an 
increase of the free GABA levels in the cerebrospinal fluid, therefore potentially 
increasing seizure threshold (Ben-Menachem, 1995). 
Importantly, also the connection between vagus nerve, thalamus and limbic system 
would be fundamental in the VNS mechanism of action. The midline and intralaminar 
nuclei of the thalamus have a widespread influence on neocortex and appear to be 
related to an “arousal-desynchronized” cortical state (Steriade and Glenn, 1982; van der 
Werf et al., 2002) which has been implicated in VNS seizure-reduction mechanism 
(Jaseja, 2010). The thalamic nuclei receive several brainstem afferent inputs, including 
NTS, LC and RN (Krout et al., 2002). Theoretically any manipulation that interrupts 
any thalamic pathological activity would also interrupt the spread of the seizure activity 
as it travels across the neocortex (Fanselow, 2012).  
Also the limbic system, which is heavily implicated in many epilepsy types, receives 
afferent input from LC and norepinephrine concentrations are increased in the limbic 
system by VNS (Roosevelt et al., 2006).  
Studies employing neuroimages such as Positron Emission Tomography (PET) and 
Single Photon Emission Computed Tomography (SPECT) have tried to further 
elucidate the role of cortical and/or subcortical regions associated with VNS, showing 
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regional metabolism changes in some cerebral areas during treatment, such as the 
ipsilateral anterior thalamus, cingulate gyrus, cerebellum, hypothalamus and insular 
cortices (Chae et al., 2003; Henry et al., 1999, 2004; Ring et al., 2000). 
Henry and colleagues (1999) also found that PET scans performed during VNS 
treatment, demonstrated increases in thalamic blood flow with positive correlations with 
the anticonvulsant effects and seizure responsiveness. Altogether, these findings show 
that VNS is potentially able to interact with cortical functioning and activity through a 
series of brainstem-cortical interconnections, such as monoamine nuclei, thalamus and 
limbic system, all of which may affect the brain propensity to generate seizures (Figure 
1).  
However, due to the lack of understanding of epilepsy mechanisms and the precise 
brainstem sites of action, how VNS exactly exerts is therapeutic effect remains 
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Figure 1. From Fanselow, 2012 






2.1.1.2 Clinical indications and efficacy 
 
The incidental findings about the concomitant improvement in mood, cognition, and 
well-being during VNS therapy in DRE, have raised interest regarding the utility of this 
treatment in neurological disorders other than epilepsy, such as cognitive, mood and 
behavioural disturbances, headache and migraine, multiple sclerosis and sleep disorders 
(Attenello et al., 2016; Beekwilder and Beems, 2010; Yuan and Silberstein, 2016). 
Further, according to some authors, VNS might act restoring the imbalance between 
sympathetic and parasympathetic tone which has been implicated in the 
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pathophysiology of a number of other disorders, such as heart failure, inflammatory 
bowel disease and chronic pain syndromes (Ghia et al., 2006; De Ferrari et al., 2011). 
However, apart from severe, chronic and recurrent depression in patients >18 years and 
focal-onset DRE in patients >12 year of age, who already received FDA approval for 
VNS treatment in 2001 and 1997 respectively (Cyberonics, Inc., 2012), all the other 
therapeutic aspects are still under investigation and may represent in the future 
promising indications for VNS therapy. 
The first use of VNS in the treatment of DRE in humans was in 1988 by Penry and 
Dean (1990) which led, during the subsequent years, to a number of clinical trials and 
publications assessing efficacy, safety, and tolerance of VNS therapy. 
The evidence for the efficacy and subsequent the approval of VNS for epilepsy 
treatment was based on two randomized, double-blind, active-controlled trials named 
EO3 and EO5, respectively. 
EO3 was conducted in 1995 by the VNS study group (The Vagus Nerve Stimulation 
Study Group, 1995) which compared efficacy of VNS in 114 patients divided in two 
active groups and receiving high (30 s ON and 5 min OFF, 30 Hz, 500 μs, up to 3.5 
mA) or low (30 s ON and 90 min OFF, 1 Hz, 130 μs, ≤ 3·5 mA) stimulation current and 
followed up for 12 weeks. The true placebo group was not possible because VNS output 
currents are felt by the patients. The mean seizure reduction was 24.5% vs 6.1% in high- 
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and low-stimulation groups, respectively (p = 0.01). Thirty-one percent of patients 
receiving the high stimulation had a reduction of 50% or more in seizure frequency.  
EO5 study (Handforth et al., 1998) was conducted on 190 patients with similar 
stimulation regimens to the EO3 study, followed up for 12 weeks.  After 3 months of 
stimulation there was a 28% decrease in seizures in the high-stimulation group and a 
15% decrease in the low-stimulation group (p=0.039). Between-group comparisons for 
50% responders were not significant (23.4% vs 15.7%). However, the high-stimulation 
group was more likely to achieve a 75% seizure reduction than the low stimulation 
group (10.6% vs 2.0%). 
Subsequently, there have been two major prospective, long-term follow-up studies that 
assessed the change in seizure frequency and tolerability from the end of the previous 
clinical trials (EO3 and EO5) for up to 1 year (DeGiorgio et al., 2000) and up to 3 years 
(Morris and Muller, 1999). In the study by DeGiorgio et al. (2000) patients were 
followed-up for 1 year and showed a median seizure reduction of 45% and seizure 
reduction rates of ≥50% or ≥70% in 34% and 20% respectively. In the EO1–EO5 study 
(Morris and Muller, 1999), a total of 440 patients were followed up for 3 years. Seizure 
reduction of more than 50% was seen in 23% of patients at 3 months, 36.8% at 1 year, 
and 43% at both 2 years and 3 years. 
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Overall, while efficacy of VNS seems to increase over the time of treatment, reaching a 
plateau after one to two years (50%-60% of patients achieve ≥50% reduction rate in 2 
years) (Morris and Mueller, 1999), side-effects tend to decrease progressively during 
the follow-up (Englot et al., 2011). Complete seizure freedom is achieved instead in 
only a small (8%) percentage of patients (Englot et al., 2016). 
VNS seems to exert the most of its therapeutic effects with prolonged treatment (long-
term) rather than as an immediate consequence of acute stimulation. The facts that 
efficacy may increase in long-term use suggests that VNS may not only work via 
immediate stimulation but also through a mechanism of brain network remodulation 
towards a less epilepsy-prone state (Schulze-Bonhage, 2017). 
In 2015, Cochrane Epilepsy Group (Panebianco et al., 2015) published updated 
evidence regarding the efficacy and tolerability of VNS treatment in DRE. Authors 
recruited a total of five trials and 439 participants and showed that the overall risk ratio 
(95% CI) for ≥50% reduction in seizure frequency across all studies was 1.73 (1.13 to 
2.64) and that high frequency VNS was over one and a half times more effective than 
low frequency VNS. 
According to the AAN guideline published in 2013 (Morris et al., 2013), invasive VNS 
received level C evidence for achieving >50% seizure reduction in DRE patients and 
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may be considered for seizures in children, for Lennox-Gastaut syndrome associated-
seizures and for improving mood in adults with epilepsy (Level C).  
 
2.1.1.3 Adverse effects 
The more VNS device has been used over the years, the more we have learned about the 
adverse events associated with this neurostimulation method.  
Adverse events can be divided into acute, essentially related to surgery procedure and 
long-term events, principally related to the nerve stimulation per se.  
Postoperative infections have been reported in 3–6% of patients (Handforth et al., 1998; 
DeGiorgio et al., 2000; Ben-Menachem et al., 1999) which led to device removal in 
three of 198 (1.5%) patients in EO5 study (DeGiorgio et al., 2000). Reversible left vocal 
cord paralysis occurred in one patient in the EO3 study and in 2 patients in the EO5 
study. Lower facial weakness was reported in 2 patients in the EO3 study and in 1 
patient in the EO5 study. Ventricular asystole during testing of the device on 
implantation has been estimated one in 875 (0.1%) patients (Ben-Menachem, 2002). 
In 1999, Morris and Mueller published all the side effects collected from patients 
enrolled and followed-up in five previous clinical trials. The most common adverse 
events were hoarseness (28%) and paresthesias in throat-chin region (12%) after 1 year, 
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hoarseness (19%) and cough (5.9%) after 2 years and shortness of breath (3.2%) after 3 
years (Morris and Mueller, 1999; Beekwilder and Beems, 2010; Ben-Menachem, 2002) 
(Figure 2).  
The symptoms were mild or moderate, often reversible and improved with time, rarely 
requiring reduction of the stimulation intensity or adjustment of other stimulation 
variables and seldom the removal of the device. No changes in autonomic function were 
seen, such as blood pressure, heart rate, Holter monitor measures, lung function, or 
blood chemistry.  No idiosyncratic side-effects have been reported after 12 years of 
experience, and VNS did not seem to interact with antiepileptic drugs. Central nervous 
system (CNS) side effects, such as tiredness, psychomotor slowing, irritation, and 
nervousness have not been frequently reported and they did not stand out as major side-
effects of VNS. Importantly, VNS treatment did not show excessive death rates 
compered to controls and SUDEP were lower than in similar groups of DRE patients 
not receiving VNS treatment (Ben-Menachem, 2002). 
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Figure 2. Long-term VNS side-effects based on Handforth et al., 1998
(*18)
, DeGiorgio et al., 
2000
(*30)
, Ben-Menachem et al., 1999
(*51)






2.1.2 Trigeminal nerve stimulation (TNS) 
 
 
Transcutaneous TNS represents a relative new neuromodulation approach. It received a 
CE mark in September 2012 and it has been approved in the European Union as 
adjunctive treatment for drug-refractory partial-onset epilepsy and depression in adults 
and children ≥ 9 years of age (DeGiorgio and Krahl, 2013b). VNS has not received 
FDA approval yet, so it is available only in the European Union.  
A pulse generator device is worn externally by the patients and used to deliver bipolar 
stimulation through transdermal patch electrodes which have been applied to the 
forehead (supraorbital nerve foramina) or to the patient’s cheeks (the infraorbital nerve 
foramina) in order to bilaterally stimulate the V1 or V2 branches of the trigeminal 
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nerve, for times between 8 and 12 h, predominantly at night while asleep (Figure 3). 
Stimulation has given in open loop cyclic modality and parameters are generally set at 
120 Hz, pulse width 250 μs, up to 30 s ON and up to 30 s OFF (DeGiorgio et al., 2003; 
Nune et al., 2015; Cook et al., 2015).  
 
Figure 3. (A) The trigeminal foramen in a frontal view of the skull. The arrow points to the 




TNS offers some practical advantages compared to VNS. The external transcutaneous 
stimulation permits a safety neuromodulation effect at low cost and without the 
challenges of surgical implantation (Nune et al., 2015; DeGiorgio and Krahl, 2013b); 
also bilateral TNS appeared to be more effective than unilateral and this can permit 
larger effects at lower intensities (Fanselow et al., 2000; DeGiorgio et al., 2011).  
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Individual patients may tolerate and respond to various parameter changes so that 
patients are generally allowed to control the amplitude of the current delivered and are 
asked to use the maximum comfortable level (DeGiorgio and Krahl, 2013b). It has been 
shown that seizure-reduction effect increases as the amplitude and frequency of 
stimulation increase (Fanselow et al., 2000).  
There are currently no head-to-head trials comparing the different neuromodulation 
devices but efficacy appears to be roughly similar; hence, in the a lack of reliable 
predictors for  individual treatment response, the choice of the device is mostly based on 
individual preferences and clinical features (Nune et al., 2015; Schulze-Bonhage, 2017). 
 
 
2.1.2.1 Mechanisms of action  
 
Following the promising findings coming from VNS studies, and based on the 
hypothesis that seizure-reduction effects are not specific to the vagus nerve but can 
instead be achieved through multimodal stimulation of the reticular activating system 
(Moruzzi and Magoun, 1949; McLachlan, 1993), scientific interest moved to the 
development of novel stimulation approaches. 
In 2000, Fanselow and colleagues tried to understand whether, like VNS, TNS was able 
to generate an arousal-like effect in acute seizure models and so to reduce seizure 
activity in awake rats. 
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This was a pioneering work in understanding the efficacy and tolerability of TNS in 
epilepsy treatment, opening a new way for alternative therapeutic options in humans 
(DeGiorgio et al., 2006). 
Fanselow and colleagues (2000) demonstrated that TNS, delivered through a cuff 
electrode unilaterally or bilateraly implanted in the infraorbital branch of the trigeminal 
nerve, was able to significantly reduced EEG and behavioural seizure-like activities in 
pentylenetetrazole (PTZ) treated rats.  
This anti-seizure effect became evident for TNS delivered both in closed modality 
(seizure-triggered stimulus) and in open cyclic modality and appeared effective in 
reducing the synchronous seizure activity detected on field potential traces which had 
been recorded from ventral posterior medial thalamus (VPM) and/or primary 
somatosensory (SI) cortex, through chronically implanted microwires. Bilateral 
stimulation was more effective than unilateral stimulation, and stimulation was well 
tolerated. 
Once again, the claimed mechanism for explaining seizure-reduction effect was the 
indirect stimulation of subcortical structures leading to nonspecific generalized arousal 
via the reticular-activating system.  
This was supported by previous work by Moruzzi and Magoun (1949) demonstrating 
that stimulation of the midbrain reticular formation causes EEG desynchronization and 
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by the fact that Fanselow and colleagues (2000) interpreted the reduction in frequency 
and duration of the filed potential seizure-like signals, as an index of desynchronization 
of thalamic and cortical activity.  
The trigeminal nerve has three afferent branches which collect afferent sensory 
information (e.g. tactile and pain) from the different regions of the face and project 
them to the CNS via trigeminal ganglion towards trigeminal nuclei and then to the VPM 
of thalamus and (SI) cortex.  Trigeminal nuclei in turns also project to multiple nearby 
nuclei in the brainstem, including the LC and the NST, which we have already known 
being fundamental stations interposed from brainstem to CNS with potential 
neuromodulation and seizure-preventing activity (Krahl and Clark, 2012).   
This buttom-up mechanism (from peripheral nerve, subcortical structures to the cortex) 
has been postulated also for VNS, since vagus nerve shared part of the abovementioned 
widespread projections with trigeminal nerve (Fanselow, 2012).  
However, in addition to the vagus nerve, the trigeminal nerve has a more direct and 
faster pathway (10 ms from the periphery to SI) through which peripheral signals 
rapidly propagate to the VPM and then to SI.  
It is possible that neocortical activity, resulting from these afferent modulating inputs, 
may cases or prevents spreading of seizures playing a primary role in the therapeutic 
effects of TNS (Fanselow, 2012).  
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While it seems to be clear that subcortical structures play a fundamental role in seizure 
regulation mechanisms by TNS (Mercante et al., 2015, 2017; Pilurzi et al., 2015; 
Fanselow, 2012), evidence regarding the TNS capacity to alter cortical excitability is 
scarce and inconclusive (Axelson et al., 2014; Mercante et al.,  2015; Fanselow and 
Noel, 2010). 
Recently published works provided evidence regarding TNS-induced brainstem 
modulation (Mercante et al., 2015, 2017) and brainstem plasticity (Pilurzi et al., 2016) 
in heathy subjects, while cortical excitability of the primary motor cortex (M1) and 
sensorimotor integration at cortical level appeared unaffected by acute stimulation, 
suggesting no direct modulation of TNS on higher structures, at least for M1 (Mercante 
et al., 2015). 
A previous study by Axelson and co-workers (2014) confirmed that TNS does not 
acutely affect cortical excitability of M1 in healthy subjects studied with transcranial 
magnetic stimulation (TMS) protocol before, during and after 40 min of 120 Hz 
bilateral external continuous TNS. 
However, a direct and frequency-dependent inhibition of neuronal firing in SI cortex 
neurons in response to contralateral TNS has been recently shown in rat models 
(Fanselow and Noel, 2010), providing support to the intrinsic cortical inhibition as a 
mechanisms for antiepileptic effect of TNS. 
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Neuroimaging studies also showed a widespread cortical and subcortical influence of 
TNS at different level without actually clearing this issue. PET studies showed 
metabolism changes in terms of activation in the inferior e middle frontal gyrus, 
bilateral parietotemporal cortex and bilateral anterior cingulate gyri and deactivation in 
the left parahippocampal gyrus, right sensorimotor cortex, right superior parietal area, 
bilateral temporo-occipital cortex and bilateral visual cortex (Cook et al., 2011; 
Silverman et al., 2011; Schrader et al., 2012).  
 
 
2.1.2.2 Clinical indications and efficacy 
 
The first pilot feasibility study that evaluated the safety and efficacy of TNS for 
epilepsy treatment in humans was published by DeGiorgio and colleagues in 2006. 
This study showed promising data, first indicating that transcutaneous stimulation of the 
supraorbital and infraorbital divisions of the trigeminal nerve was safe and well 
tolerated for the 6 month treatment periods and also that four (57%) of seven subjects, 
who completed ≥3 months treatment, experienced a ≥50% reduction in seizure 
frequency, as observed from clinical diaries. 
These findings supported further studies on this field (DeGiorgio et al., 2009) and few 
years later DeGiorgio and co-workers (2013a) conducted the first double-blind 
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Randomized Controlled Trial (RCT) providing Class II evidence that TNS may be safe 
and effective in reducing seizures in people with DRE showing a responder rate (i.e. 
≥50% reduction in seizure frequency) of 30.2% for the treatment group vs 21.1% for the 
active control group, for the 18-week treatment period.  
Although not significant in between-group results (difference in responder rate in active 
vs control group) the significance in the within-group results (responder rate increased 
significantly over the 18-week treatment for the active group vs controls) was 
considered sufficient to justify a CE approval.   
From 2012 TNS became available in the European Union as adjunctive treatment for 
drug-refractory partial-onset epilepsy in adults and children ≥ 9 years of age. 
The phase II randomized controlled trial was completed with a long-term follow-up 
study at 1 year, which showed a 50% responder rates at twelve months of 36.8% for the 
treatment group and 30.6% for all the subjects (Soss et al., 2015). 
Currently NeuroSigma has received an investigational device exemption to proceed 
with a Phase III double-blind pivotal trial in DRE to evaluate the efficacy of adjunctive 
TNS against sham controls (Cook et al., 2015). 
Besides DRE, TNS has been implicated in treatment of different neuropsychiatric 
disorders (Shiozawa et al., 2014), in particular for migraine (Schoenen et al., 2013) and 
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depression (Cook et al., 2010, 2013; Shiozawa et al., 2015) but only for the latter TNS 
has obtained CE approval.  
 
2.2.2.3 Adverse effects 
Overall, all the available studies on TNS treatment in DRE patients showed that this is a 
safe and well-tolerated method for DRE treatment (DeGiorgio et al., 2006,  2009, 
2013a; Zare et al., 2014; Soss et al., 2015). 
Detailed analysis of adverse events and safety, related to TNS long-term open-label 
study (DeGiorgio et al., 2009), were summarised within a Brief Communication 
published by Pop and colleagues (2011) in the journal Epilepsy & Behavior (Figure 4). 
 
Figure 4. Summary of adverse events reported during long-term open-label TNS study 




Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.    
 
Mild to moderate skin irritation was the major adverse event, being reported by eight 
(62%) of the 13 subjects and followed by mild sleepiness or a sleep disturbance (15%), 
headache (31%), tooth tingling or tooth pain. All of these side effects resolved with 
decreased stimulation intensity or discontinuation of the device. Pre-existing mood 
changes or depression was reported in six subjects (46%), unrelated to the device use. 
Anxiety (4%), headache (4%) and skin irritation (14%) were also the most common side 
effects reported in RCT (DeGiorgio et al., 2013a), while sensation of pressure on the 
head (27.7%), pain (22.2%), skin reaction (16.6%) and tingling (16.6%) were the most 
common adverse effects reported in the study by Zare et al. (2014). 
No significant acute or long-term adverse effects on heart rate or systolic or diastolic 
blood pressure were warned by all the studies (DeGiorgio et al., 2006, 2009, 2013a; Pop 
et al., 2011; Soss et al., 2015). 
 
 
3. EFFECT OF PERIFERIC NEUROSTIMULATION ON BACKGROUND EEG 







The hypothesis that VNS might influence cortical EEG activity took hold in the 20
th
 
century from animal studies. In 1938 Bailey and Bremer first described an increased 
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EEG potentials recorded at the frontobasal cortex of encéphale isolé cat after the 
stimulation of the central part of the dissected vagus nerve.  
Their publication was followed by several other animal studies describing induced EEG 
background activity changes after VNS, both in terms of EEG desynchronization 
(Zanchetti et al., 1952; Moruzzi and Magoun, 1949) and synchronisation, depending on 
the stimulation parameters used and on the histological composition of the nerve fibers 
receiving the electrode impulses (Chase et al. 1967; Magnes et al., 1961).  
Chase and colleagues (1967) found that the EEG background activity was synchronized 
when cervical VNS was able to activate the faster-conducting, low threshold 
myelination A- and B-fibers, whereas when stimulus parameters were adjusted to 
activate C-fibers, the EEG became desynchronized. 
Because seizure is characterized by highly degree of EEG synchronous activity, it was 
hypothesized that desynchronization of the cortical activity would be the mechanism of 
the anticonvulsant effect exerted by VNS. 
Hence, based on these observations C-fibers were initially considered necessary for the 
anticonvulsive mechanism of VNS.  
However, subsequent findings proved that the activation of C-fibers were clearly not 
required for the anticonvulsant effect of VNS (Krahl et al., 2001) as demonstrated by 
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the clinical absence of pain sensation and significant autonomic changes after VNS in 
humans (Banzett et al., 1999; Lotvall et al., 1994). 
The induced widespread cortical desynchronization seen after VNS has been linked to a 
state of nonspecific arousal, similar to full vigilance or alertness state induced by 
indirect activation of reticula system in the brainstem, effect which appeared not 
exclusive for VNS. Other animal studies previously described similar neuronal 
desynchronization after stimulation of other peripheral nerves interposed to cortical 
ascending pathways (Pompeiano and Swett, 1962). Moreover in 1993, McLachlan 
showed that aspecific sensory or behavioural stimulation, such as placement of rats' tails 
into hot water, reduced interictal spike frequency in the same manner as VNS, probably 
thorough an indirect stimulation of reticular activating system.  
Therefore, supported by a large amount of animal evidence, for the subsequent years the 
EEG-desynchronization effect was considered the major mechanism of anti-epileptic 
action of vagal nerve stimulation in patients with DRE (Jaseja, 2010).  
Being clear since now that long-term VNS is able to clinically reduce seizure frequency 
(Panebianco et al., 2015) and that such effect might be mediate from an aspecific 
cortical desynchronization induced through the stimulation of different ascending 
subcortical projection systems (Jaseja, 2010; Fanselow, 2012), understanding whether 
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and how VNS exactly modifies human background EEG activity have been the aim of 
different studies over the last decades.  
 
 
3.1.1 Epileptiform activity changes 
 
 
The anti-seizure effects of short-term, and less often long-term, VNS protocols have 
been largely documented from animal experiments comprise stimulation administered 
just before, during or after the onset of induced seizures, which showed that VNS is able 
to suppress many different seizure types as demonstrated by ictal EEG findings 
(Aalbers et al., 2011).  
Human studies objectively showing interruption or reduction of ictal EEG seizure 
activity by VNS are instead very scarce (Ravan et al., 2017a, 2017b; Hallbook et al., 
2005) or even only anecdotal (Hammond et al., 1992; Salinsky and Burchiel, 1993), 
probably because of the difficulties in evoking or predicting seizures and so in 
conceiving and developing a reliable study design on this regard. Hence, the efficacy of 
VNS, in terms of seizure reduction during clinical trials, has been generally based on 
clinical diary reporting.  
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Most of the human studies have been instead focused on the short- and long-term effect 
of VNS on interictal epileptiform discharge (IEDs) change detection in DRE patients; 
however showing inconsistent or conflicting results. 
In 1992 Hammond and colleagues failed to show any acute changes in IEDs burst 
duration or morphology during VNS in 9 patients with DRE. 
This finding was later contradicted by Koo (2001) which observed a statistically 
significant reduction in IEDs and an increased periods of spike-free intervals, in 
subsequent EEGs collected from 21 VNS-implanted DRE patients which had been 
followed up to 3, 6 and 12 months. This EEG interictal changes have been found higher 
in patients who demonstrate active and frequent epileptiform activity, irrespective of the 
patients’ seizure control. 
One year later, also Kuba and colleagues (2002) found that short-term VNS was able to 
reduce IEDs significantly and that the value of IEDs reduction was higher in DRE 
patients who showed to clinically respond to VNS. The same effect was then confirmed 
from the same group also in a long-term analysis, in patients chronically stimulated with 
VNS (Kuba et al., 2010).  
In 2004, Rizzo and colleagues again failed to detect significant changes in IEDs 
reduction during long-term VNS treatment, although they described a trend towards a 
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decrease in the number of IEDs and a significant shortening in the duration of the 
discharges (Rizzo et al., 2004). 
Also Santiago-Rodrıguez and colleagues (2006) showed inconclusive results from their 
work, acute VNS modified number and duration of IEDs in 80% of patients undergoing 
the 30 s/5 min cycle stimulation but it did not show any effect at 7 s/18 s cycle; however 
in 20% of patients, both cycles increase the epileptiform activity. 
However, the subsequent works from Hallbook et al. (2005) and Wang et al. (2009) 
appeared concordant while showing that long-term VNS is able to induce a statistically 
significant progressive decrease in the number of IEDs in treated DRE patients. 
In conclusion, although no definitive and conclusive results can be drown from the 
findings above, this does not mean that acute or long-term VNS have any therapeutic 
effect on DRE patients. Indeed, it is already well known that clinical outcome does not 
necessary correlate with EEG interictal findings and also, since VNS efficacy has been 
shown to increase over the time, probably with a mechanism of network remodulation 
(Schulze-Bonhage, 2017; Fraschini et al., 2014), long-term EEG VNS-effect may not be 
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 3.1.2 Quantitative EEG analysis 
Besides VNS-induced IEDs pattern modulation, another interesting field of 
investigation is whether and how VNS may affect the architecture of background EEG 
dynamics, in terms of quantitative spectral analysis and correlations between signals. 
This issue has been investigated by different authors over the years.   
Starting from the hypothesis that VNS is able to induce a cortical desynchronization on 
EEG activity of animal models (Aalbers et al., 2011), Salinsky and Burchiel (1993) 
tried to define the acute effects of VNS on human EEG background rhythm 
composition.  They concluded that VNS, at the parameters in current clinical use, does 
not alter the awake EEG background rhythms, either in term of EEG total power and 
median frequency, or in power of any conventional frequency bands, also in those 
patients with apparent clinical response. Therefore their results did not support the 
hypothesis that VNS produces acute desynchronization in human awake EEG. 
Also Hammond and colleagues (1992) showed that acute VNS (at stimulus frequencies 
of 1, 5, 10, and 50 Hz) had no effect on the EEG background rhythm composition of 
awake, sleep or anesthetized patients. 
However, in 2004 Rizzo and colleagues evaluating the impact of chronic VNS on 
sleep/wake background EEG activity showed an increase in the EEG total power and a 
statistically significant increase in delta and theta rhythm in NREM sleep, and of alpha 
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in wakefulness and REM sleep. They suggested that only long-term VNS produces, 
instead of an EEG desynchronization effect, an enhancement in normal background 
rhythms which characterised each sleep/wake state, maybe enhancing brain’s ability to 
generate a better structured electrical activity.  Contrariwise, no direct effect of acute 
VNS was presented in sleep/wake EEG, in line with findings of previous authors. 
One year later, Marrosu and colleagues (2005) investigated in their work both the EEG 
power spectra and the inter- and intra-hemispheric synchronization (coherences of EEG 
signals) changes of the EEG frequency bands in 19 long-term VNS-treated DRE 
patients, compared to a control group of 10, only AED treated, DRE patients. They 
found that VNS decreased synchronization of theta frequencies and increased power 
spectrum and synchronization of gamma bands (20–50 Hz) in the VNS treated group, 
compared to controls. Authors proposed these findings as a possible explanation of 
VNS anticonvulsant mechanism, considering the gamma band enhancement as a kind of 
“protective effect” against seizures.   
The same group, in a subsequent paper (Fraschini et al., 2013), investigated the 
correlation between variations of global EEG synchronization and the clinical outcome 
(VNS responders vs non-responders) in 10 long-term VNS-treated DRE patients. The 
investigation was conducted with a different methodological approach, the phase lag 
index (PLI), which allowed the study of the global rate of synchronicity among the EEG 
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signals before and after VNS implantation and lead to different interpretation of the 
EEG analysis. They found that VNS induced a desynchronization in the gamma 
frequency band which was statistically significant in VNS responders compared to the 
non-responder group and they interpreted the global desynchronization in gamma band 
as a potential part of the antiepileptic effect exerted by VNS, other than a possible new 
tool in assessing the efficacy of VNS treatment. 
The PLI index was later used also by Bodin and colleagues (2015) who studied the level 
of synchronicity of inter-ictal EEG rhythms in 19 patients undergoing chronic VNS 
therapy, between pre- and post-VNS treatment, ON and OFF stimulation phases and 
between responder (R) and non-responder (NR) patients. The main results were that 
patients with a good response to VNS have a lower level of synchronization in the 
interictal state than non-responders (particularly in delta and alpha bands). They also 
found that stimulation (ON) periods were associated with a decrease in synchrony in 
comparison with the non-stimulation (OFF) periods. Once again, the hypothesis of 
VNS-induced EEG desynchronization was confirmed from a human study and 
interpreted as a mechanism of seizure prevention.  
Overall, to summarize findings above we can conclude that the inconsistency reported 
in the study results has probably to be attributed to the large variability and differences 
in study design, including individual and group characteristics, VNS stimulus 
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parameters, different methodological approach for the analyses and the result 
interpretation.  
Therefore, after almost two decades of VNS utilization, its mechanisms of action, and 
so how it is able to clinically determine a significant seizure reduction in DRE patients 
(i.e. interfering with interictal/ictal discharges or modulating background rhythm 
composition and/or synchronisation), appears still unclear.  
 
1.2 TNS 
Evidence regarding EEG background changes following TNS protocol in human and 
animal models is very scares, also compared to the large amount of studies relative to 
VNS, as seen above. This might be due to the relative lower widespread availability of 
the novel method (European Union only), which has determined its lower use, and the 
more recent launch and approval obtained from CE.   
 
3.2.1 Epileptiform activity changes 
The first evidence regarding objective EEG epileptiform activity changes after TNS 
comes from the study of Fanselow et al. (2000) where they showed that the number and 
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the frequency of PTZ-induced seizure activities were reduced during the stimulation of 
the infraorbital nerve after cyclic and automatic seizure-detection delivery.  
To demonstrate that, authors implanted several microwires in VPM of the thalamus and 
SI cortex in rat brains, in order to recorded field potential changes as index of seizure 
activity. The two indicators of seizure activity were highly synchronous, large-
amplitude above-threshold activity in the thalamic and cortical field potential traces and 
the corresponding presence of behavioural changes (i.e. clonic jerking of the body and 
forelimb).  
They found that stimulation of the infraorbital nerve was able to stop synchronous 
seizure-like activity and to reduced frequency and duration of seizures in a current-
dependent manner by up to 78%. 
Recently some animal studies focused on TNS-induced behavioural changes in rats after 
PTZ or Pilocarpine injections, showed promising and consistent results in terms of 
seizure reduction and TNS effectiveness compared to sham controls (Wang et al., 2016; 
Mercante et al., 2017). However, epileptiform EEG changes following TNS have been 
not evaluated in either of those mentioned studies.  
Mercante and co-workers (2017) performed a behavioural pattern analysis, by means of 
the Racine's scale visual scores, in 10 male rats treated with real or sham TNS, during 
pentylenetetrazole (PTZ)-induced seizures. They found that in comparison with sham 
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groups, TNS significantly decreased the duration of PTZ-induced seizures (p<0.05) and 
promoted a faster recovery (p<0.001) by reducing the most severe seizure types.  
Regarding humans, there is only one published study which anecdotally reported a 
refractory status epilepticus (RSE) ceasing and EEG improvement after the adjunctive 
treatment with TNS in a DRE patient (Moseley and DeGiorgio, 2014).  
 
3.2.2 Quantitative EEG analysis 
 
So far, only one clinical case has been published on quantitative EEG analysis after 
TNS treatment in a 60-year old female patient with drug-resistant depression 
(Shiozawa, 2016).  
Ten daily TNS sessions (with an interval in the weekend), of 30 min each was 
performed. The electrodes were placed over the two supraorbital branches of the 
trigeminal nerve and the stimulus parameters were set a 120 Hz, 250 μs, with current 
intensity adjusted for a nonpainful paresthesia as reported by the patient. Five minutes 
of continuous EEG was recorded at baseline and after the 10-day TNS protocol. A fast 
Fourier transform was used to calculate absolute power (AP = μV2) in each of the six 
frequency bands (delta: 0.5–4 Hz, theta: 4–8 Hz, alpha 1: 8–10 Hz, alpha 2: 10–2 Hz, 
beta: 12-30 Hz, gamma: 30–60 Hz). After 10-day TNS protocol a cortical widespread 
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increase in delta band power and a parieto-occipital increase for alpha 1 and 2 power 
were noted during the eye close condition.  
To the best of our knowledge, data on qualitative and quantitative EEG analysis 
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1. BACKGROUND AND AIMS 
 
Drug-resistant epilepsy (DRE) accounts for 30% of the worldwide epileptic patients for 
whom, despite adequate pharmacological therapies, seizures are not completely 
controlled (Kwan et al., 2010). Excluding a little percentage of DRE patients eventually 
suitable for curative epilepsy surgery, most of them continue to have lifelong disabling 
seizures with a significant burden on quality of life (Fois et al., 2015; de Tisi et al., 
2011).  
Following the increasing need for novel therapeutic options for DRE and based on 
historical observations that electrical stimulation of peripheral nerves and subcortical 
structures could modify cortical excitability (Pompeiano and Swett, 1962; Moruzzi and 
Magoun, 1949; McLachlan, 1993), a number of neuromodulation devices have been 
developed over the past few decades.  
Vagal nerve stimulation (VNS) represents the most widely used neurostimulation 
method, being the only peripheral approach currently approved by the US Food and 
Drug Administration (FDA) as an adjunctive treatment for partial-onset DRE and 
showing a 1-year responder rate (≥50% reduction in seizure frequency) by up to 36.8% 
of the treated patients (DeGiorgio et al., 2000; Morris and Mueller, 1999).  
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However, in the last decade a large body of evidence has supported the use of an 
alternative peripheral neuromodulation method, named trigeminal nerve stimulation 
(TNS).TNS has recently received European Conformity (CE) marking as a promising 
additional treatment for intractable epilepsy (1-year responder rate of 36.8%) (Soss et 
al., 2015).  
It has been reported that TNS has some advantages in comparison with the well 
acknowledged VNS. While VNS implantation represents an invasive procedure, 
carrying the risk of surgical intervention and different adverse effects (Ben-Menachem 
2002, 2015), TNS is an external peripheral method which can be safely used and easily 
self-administered by the patient (Pop et al., 2011). Moreover, the absence of autonomic 
fibers in the trigeminal nerve allows a bilateral stimulation with larger effects at lower 
intensities compared to unilateral stimulation as routinely used for VNS (DeGiorgio et 
al., 2003; Fanselow et al., 2000).  
Despite their clinical utilization, yet mechanisms underlying the anticonvulsant effect of 
cranial nerve stimulations are not completely understood.  
A number of animal and human epilepsy models suggested that VNS may modulate 
cerebral activity by inducing an electroencephalographic (EEG) desynchronization and 
so a cortical inhibition, lowering the excitability of the epileptogenic tissue (Zanchetti et 
al., 1952; Aalbers et al., 2011; Jaseja, 2010; Fraschini et al., 2013; Bodin et al., 2015).  
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As well as VNS, also TNS has been shown to influence cortical activity in a single, 
pioneering experimental epilepsy model, by means of a thalamo-cortical, stepwise, EEG 
desynchronization effect (Fanselow et al., 2000).  
This is in line with the bottom-up hypothesis which attributed the cortical neuronal 
modulation to an indirect stimulation of subcortical stations interposed to higher 
ascending pathways (Shiozawa et al., 2014; Fanselow, 2012). 
Trigeminal and vagus cranial nerves share widespread projections to different 
subcortical structures with cortical neuromodulatory effects; therefore they may be also 
supposed to share some of the anticonvulsant mechanisms (Fanselow et al., 2000; 
Fanselow, 2012; Mercante et al., 2015, 2017; Pilurzi et al., 2016). 
However, whether and how TNS is able to modulate human cortical excitability and 
background EEG dynamics, in DRE patients is still unknown. 
Recently neurophysiology works provided evidence regarding TNS-induced brainstem 
modulation (Mercante et al., 2015, 2017) and brainstem plasticity (Pilurzi et al., 2016) 
in heathy subjects, while primary motor cortex (M1) excitability and sensorimotor 
integration at cortical level appeared unaffected by acute stimulation, suggesting no 
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Contrariwise, a frequency-dependent inhibition of neuronal firing in primary 
somatosensory cortex (SI) neurons, in response to contralateral TNS, has been recently 
shown in rat models (Fanselow and Noel, 2010), in accordance with the previous work 
which showed EEG spike suppression in SI and thalamus after TNS delivery (Fanselow 
et al., 2000).  
Therefore, while it seems clear that subcortical structures play a fundamental role in 
seizure regulation mechanisms by TNS (Mercante et al., 2015, 2017; Pilurzi et al., 
2016; Fanselow, 2012), evidence regarding the TNS capacity to alter cortical 
excitability and/or EEG dynamics is scarce and inconclusive (Axelson et al., 2014; 
Mercante et al., 2015; Fanselow and Noel, 2010; Fanselow et al., 2000) and cannot be 
easily translated to DRE patients as explanation of TNS clinical benefits. 
Indeed, TNS cortical modulation effects, by means of background EEG activity changes 
in DRE patients, has neither be proved nor investigated.  
With this study, we aimed to evaluate the effect of acute TNS protocol on cortical EEG 
background activity in DRE patients, by conducting a qualitative (morphologic) and 
quantitative (power spectra) EEG analyses in an active vs a sham-TNS group, to better 
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2. MATERIALS AND METHODS 
2.1 Subjects 
 
Twenty-two subjects affected by DRE (11 females and 11 males; 48.77 ± 13.16 years 
old; range 27-68 years), who attended the Center for Diagnosis and Treatment of 
Epilepsy at the Unit of Neurology, University of Sassari (Italy), were recruited for the 
study. They were selected based on the following inclusion criteria: age 18–70 years; 
diagnosis of focal DRE (Kwan et al., 2010) with ≥2 partial or secondary generalized 
tonic-clonic seizures (GTC) per month for the last 2 consecutive months and concurrent 
use of ≥1 antiepileptic drug (AED).  
Exclusion criteria included history of diabetes, migraine or trigeminal neuralgia; 
presence of cardiovascular diseases (such as arrhythmia, heart failure or ischemic heart 
disease) or other serious medical or psychiatric conditions and ongoing pregnancy. 
Characteristics of selected patients are summarized in Table 1. 
The experimental procedure was approved by the local ethical committee (Bioethics 
Committee of ASL n.1 Sassari, Prot n. 982/CE) and conducted in accordance with the 
Helsinki Declaration. An informed written consent was obtained from all the subjects 
before conducting the study. Patients were divided into two groups “sham-“or “real-
TNS”: after baseline evaluation, 22 opaque envelopes were numbered consecutively and 
randomly assigned to an intervention (Real-TNS; n = 11) or to a no-intervention (Sham-
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TNS; n = 11) group, with a blocking procedure employing the Research Randomizer 3.0 
software. Both subject and statistician were blinded for the type of intervention. 
 
Table1. Characteristics of subjects divided for Sham- and Real-group. 
 
SHAM-GROUP 




Lesion N of seizures 
(/month) 
AEDs 
1 F 52 RFr Malacic 7 LEV+LTG 
2 M 65 LT HS 2 VPA+PER+PRI+LEV 
3 M 67 LFr Schizencephaly 3 OXC+LEV+PGB 
4 M 44 LO Gliosis 2 PER+LTG+LAC 
5 M 61 RT HSE 15 LAC+LEV+CBZ 
6 M 42 LFr Malacic 15 VPA+LTG+TPM 
7 M 53 RT Crypto 7 CBZ+LAC+VPA+LEV 
8 F 54 RP SAH 8 CBZ+LEV 
9 F 46 RT Crypto 8 LTG 
10 F 66 LT Crypto 18 LEV+LTG 
11 M 35 LT Crypto 35 LEV+LTG 
REAL- GROUP 
1 M 31 LFr Crypto 2 CBZ+LTG 
2 M 65 LT Crypto 2 CBZ 
3 F 27 RT HS 4 LEV+LAC 
4 M 68 BFr Crypto 2 LEV+PB+CBZ 
5 M 49 RFr RE 3 LEV+CBZ 
6 F 37 RO Crypto 2 TPM 
7 F 31 RFr Malacic 10 VPA+ LTC+LAC 
8 F 57 LT Crypto 15 CBZ+ZNS 
9 F 51 RT Crypto 17 CBZ+LEV 
10 F 35 BT NH 3 LEV+LTG+LAC 
11 F 37 RT FCD 40 LEV 
       
F, female; M, male; R, right; L, left; B, bilateral; Fr, frontal; T, temporal; P, parietal; O, occipital; Crypto, cryptogenic; 
FCD, focal cortical dysplasia; HS, hippocampal sclerosis; HSE, Herpes simplex encephalitis; NH, nodular heterotopia; 
RE, Rasmussen encephalitis, SAH, subarachnoid hemorrhage; CBZ, carbamazepine; LAC, lacosamide; LEV, 
levetiracetam; LTG, Lamotrigine; OXC, oxcarbazepine; PB, phenobarbital; PER, perampanel; PGB, pregabalin; PRI, 
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2.2 TNS protocol 
Real-TNS was delivered bilaterally to the infraorbital nerve (ION) through 26-mm-
diameter disposable, hypoallergenic, silver-gel self-adhesive stimulating electrodes 
(Globus, Domino s.r.l., Codognè, TV, IT) placed over the ION foramina and connected 
to a Winner® stimulator (Fisioline biomedical instrumentation, Verduno, CN, IT). The 
stimulus consisted of trains of a symmetric biphasic square wave pulse (duration 0.25 
ms, frequency 120 Hz), delivered in a cyclic modality (30 s ON and 30 s OFF) for 20 
min, according to previous works (Pilurzi et al., 2016; Mercante et al., 2015; Ginatempo 
et al., 2017). Stimulation intensities ranged from 1 to 20 mA and corresponded, for each 
ION, to the maximal pain sub-threshold intensity endurable comfortably by the subject. 
The sham-TNS protocol mimicked the initial bilateral real-TNS stimulation and 
consisted of a previous calculation of both perceptual and pain threshold, followed by 
20s of TNS, the intensity of which was subsequently gradually decreased down to zero, 
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2.3 EEG recording  
EEG signals were recorded with head caps using a 19 channel EEG system (Brain 
Quick System, Micromed, Mogliano-Veneto, Italy) in physical reference with 
successive reconstructions of bipolar derivations (FP1-F3, F3-C3, C3-P3, P3-O1, FP1-
F7,F7-T3,T3-T5,T5-O1,FP2-F4,F4-C4,C4-P4,P4-O2,FP2-F8,F8-T4,T4-T6,T6-O2,FZ-
CZ,CZ-PZ) according to the international 10–20 system. EEG was acquired in eyes-
closed resting state, band pass filtered between 0.5 and 70 Hz and digitized with sample 
frequency set at 256 Hz. EEG was continuously recorded for a 40-minutes period 
comprising 3 phases: (i) 10 minutes of baseline EEG, recorded before TNS (pre) (ii) 20 
minutes during the intervention (real- or sham-TNS) (iii) 10 minutes after intervention 
(post). Electrocardiogram and electrooculogram (EOG) were simultaneously monitored 
in all subjects (time constant: 0.3 s, filter 30 Hz). EOG was recorded from the 
orbicularis oculi muscle by surface electrodes, with the active electrode placed over the 
mid lower eyelid and the reference 2–3 cm lateral. 
 
2.3.1 Qualitative analysis (IEDs detection) 
 
The EEG recordings were visually analyzed. Artifacts due to eye blinks, horizontal–
vertical eye movements, muscle contractions and possible signs of sleepiness were 
detected by visual inspection and deleted.   
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Only definite spikes, sharp waves, and spike-wave complexes were considered 
epileptiform abnormalities and distinguished from the background activity due to their 
morphology and/or amplitude. Two different paradigms were visually analyzed: the 
absolute number of interictal epileptiform discharges (IEDs) for each time points and 
the ratio between the number of IEDs and the minutes of time points in which they 
appeared. Both calculations were included in the statistical analysis.  
 
2.3.2 Quantitative analysis (power spectra) 
 
Bipolar EEG signals of each recording were processed by spectral analysis: Fast Fourier 
Transform (FFT) was applied to 4-sec artifact-free basic epochs and mean spectra were 
computed according to the Welch’s method (with Tukey window) for each phase (pre, 
during and post). Due to the overlapping of the stimulation artifact with EEG signals, 
the analysis of data collected during TNS (real or sham) was limited to the OFF phase 
only, with the exclusion of the 3-second periods at the beginning and end of it. Based on 
mean spectra, mean power was computed for each frequency band: delta (0.5-3 Hz), 
theta (3.1-7.0 Hz), alpha (7.1-13 Hz), beta (13.1-30 Hz) and gamma (30-48 Hz). Power-
weighted mean frequency was computed in a large band (0.5-48 Hz) in order to measure 
a possible global frequency shift (Figure 1). 
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Figure 1. Schematic representation of EEG recording and analysis process in pre, during and post 
TNS. FFT, Fast Fourier Transform Analysis. 
 
2.4 Statistical analysis 
Paired t test was performed to evaluate demographic features between groups for age, 
sex, number of seizures and number of AEDs. A between and within subject repeated-
measures ANOVA was used with TIME (pre, during and post TNS), CONDITION 
(sham, real) and DERIVATION (spatial position) as factors for each variable (mean 
frequency and absolute power of each frequency band).  
Given the large number of comparisons, values were corrected for multiple comparisons 
using the false discovery rate (FDR) method (Benjamini and Hochberg, 1995) which is 
less conservative than Bonferroni correction, and better suitable for assessing global 
variations. Data analysis was performed using the SPSS 18 software (SPSS Inc., 
Chicago, IL, USA). 
 
EEG-PRE 10 min 
EEG visual inspection and Artifact rejection 
FFT Analysis 







Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 




No significant difference in any of the demographic features or in EEG quantitative and 
qualitative patterns was observed between sham- and real-TNS groups in either 
condition at baseline (age p=0.14; sex p=0.19; number of seizure p=0.49; AEDs 
p=0.11). 
3.2 IEDs detection 
Qualitative analysis of IEDs in terms of ratio and absolute values showed no significant 
effect for TIME (F2,20=0.077, p=0.46; F2,20=3.885,p=0.05 respectively), CONDITION 




















Table 2. Absolute and ratio values of IEDs shown for time (pre, during, post) and condition 
(Sham- and Real-TNS). 
Condition Patient Pre During Post Pre During Post
1 18 9 4 1.44 0.91 0.38
2 9 10 12 0.78 1.06 1.05
3 0 1 1 0.00 0.11 0.08
4 31 29 28 2.55 2.9 3.13
5 0 0 2 0.00 0 0.14
6 23 14 23 2.10 1.44 2.01
7 40 46 56 4.00 4.66 4.72
8 23 23 7 2.03 2.33 0.92
9 8 7 12 0.65 0.75 1.27
10 89 86 147 5.10 8.6 8.75
11 18 14 19 15.52 26.25 20.07
1 19 1 24 1.72 0.19 2.5
2 45 1 36 3.18 0.17 3.10
3 42 4 3 58.33 21.43 28.13
4 4 3 1 0.31 0.59 0.13
5 2 1 1 0.17 0.17 0.09
6 6 2 3 0.51 0.39 0.3
7 7 3 3 0.5 0.35 0.3
8 6 6 3 11.20 23.68 45
9 57 33 72 4.07 6.19 7.30
10 25 5 11 2.08 0.94 1.1
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3.3 Spectral analysis  
Repeated-measures ANOVA showed a significant effect of DERIVATION, which was 
observed for all variables. Absolute power of each band was not significantly affected 
by TIME and CONDITION and no significant TIME*CONDITION interactions were 
observed for any variable, except for the absolute power of alpha band.  
The alpha band showed a significant increase for TIME in the Real condition during 
TNS, but no significant difference between CONDITIONS. A significant interaction 
DERIVATION*TIME and DERIVATION*TIME*CONDITION was detected (Table 
3; Figure 2). 
Table 3. Repeated-measures ANOVA analysis between and within subject of mean frequency and absolute power for 
each band (delta, theta, alpha, beta and gamma) measured before (PRE), DURING and after (POST) acute TNS. The 
table shows the results of ANOVA for main effect of Derivation, Time, Condition and interaction.












































































































































A. Sham Group 
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In particular, an increase of absolute power of alpha band was detected in parieto-












B. Real Group 
Figure 3. Graphic representation of mean absolute power spectra grouped in different conditions (A. 
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DISCUSSION AND CONCLUSION 
Besides IEDs detection, a number of intrinsic background EEG abnormalities in 
quantitative and power spectra analyses have been reported in epileptic patients 
compared to healthy controls. Overall a global increase of the spectral power in the slow 
frequency range (i.e. theta and delta) and a decrease in the alpha band have been 
variously reported by many authors, possibly unrelated to AED consumption or 
syndromic variants (Pyrzowski  et al., 2015; Diaz et al., 1998; Gelety et al., 1985). 
Neuromodulation methods are supposed to influence the propensity to generate seizures 
by interfering with the background EEG activity in epileptic patients, raising the 
threshold of epileptogenic tissue and thus restoring the balance between excitatory and 
inhibitory mechanisms (Krishna et al., 2016; Dalkilic, 2017; Rocha, 2013). 
The trigeminal nerve projects to a widespread number of subcortical and brainstem 
regions with documented cortical neuromodulatory effects (Fanselow, 2012; Mercante 
et al., 2017); however, the neurobiological mechanisms by which TNS modulates brain 
function in humans and how this actually affects background EEG rhythms is unknown. 
Overall, data from this study showed that a short-term TNS protocol is able to induce an 
acute effect on the EEG background composition of focal DRE patients and its effect is 
mainly expressed as a modulation of the distribution of the signal power over 
frequencies, as demonstrated by the spectral power analysis.  
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Indeed, a consistent and significant increase of the absolute power of alpha band during 
the real TNS was observed in patients’ EEGs compared to the sham group. Alpha 
enhancement appeared during the 20 minutes of TNS-ON and partially maintained 
during the post-TNS period (10 minutes after stimulation).The alpha power 
enhancement appeared particularly localized in the parietal-occipital and frontal areas, 
unrelated to epileptogenic focus (Figure 2 and 3). Conversely, no significant effects 
were noticed either for quantitative analysis of other frequency bands (delta, theta, beta 
and gamma) or for qualitative analyses (IEDs detection).  
This positive alpha modulatory effect has been previously described following chronic 
stimulation of the vagus nerve in epileptic patients (Rizzo et al., 2004). In their work the 
authors demonstrated that VNS induced a better structured composition of the 
background EEG in these patients, while enhancing the power of the EEG rhythms 
which characterize each sleep-wake state (i.e. delta and sigma in non-REM sleep, alpha 
in both REM sleep and wakefulness). These authors suggested that VNS is able to 
induce an improvement of cortical electrogenesis, thus enhancing the brain’s ability to 
generate a normal electrical activity, possibly through metabolic changes on the 
thalamo-cortical EEG generating system.  
Interestingly, neuroimaging human studies variously reported that increased EEG alpha 
power correlates with a decreased metabolic rate in multiple regions of the occipital, 
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superior temporal, inferior frontal and cingulate cortex, but with an increased activity in 
the thalamus and insula (Goldman et al., 2002; Bazanova and Vernon, 2014).  
Extensive literature regarding the functional aspect of the alpha rhythm proposed that 
regional alpha enhancement (in terms of increased EEG amplitude) would represent a 
cortical inhibitory process useful to control cortical activation and excitability in a top-
down manner (Klimesch et al., 2007; Bazanova and Vernon, 2014). It has been 
suggested that greater levels of regional alpha amplitude are associated with inhibition 
of cortical non-essential or conflicting processing or activities and, in turn, with the 
facilitation of performance on different, more fruitful tasks (Cooper et al., 2003). 
The functional inhibition of the alpha-amplitude oscillations would play an important 
role in a variety of cognitive processes (VanRullen and Koch, 2003) as well as in 
regulating motor activity (Klimesch et al., 2007). The increase in alpha power across 
sensorimotor regions showed a strong inhibitory influence on the generation of neuronal 
firing and action potentials in monkey models (Haegens et al., 2011). 
Since a high level of excitatory neurotransmission could be a neurobiological factor that 
may underlie augmented susceptibility to develop pharmacoresistance (Rocha, 2013), a 
possible increase of inhibitory cortical activity can underpin the clinical effect of TNS 
in epileptic patients.  
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Accumulating evidence suggest that, like VNS, TNS ultimately influences the pattern of 
neuronal activity while connecting to brain areas which are thought to modulate the 
lateral reticular formation, such as the nucleus tractus solitarii (NTS) and the locus 
coeruleus (LC) (Mercante et al., 2017). These are, in turn, connected to noradrenergic 
and serotoninergic systems associated with the regulation of mood, anxiety (Ruffoli et 
al., 2011) and to glutamatergic and GABAergic systems regulating the susceptibility to 
seizures (Walker et al., 1999). NTS and LC are also considered as nuclei which 
disseminate neuromodulatory compound in the central nervous system (CNS), since 
they profoundly affect its excitability at virtually all levels and are believed to play a 
key role in mediating the clinical benefits observed from TNS procedure (Mercante et al 
2017; Krahl and Clark, 2012; Krahl et al., 1998; Fornai et al., 2011). 
Importantly, sensory input which relayed via the trigeminal nerve to the ventral 
posterior medial (VPM) thalamus, could also trigger intra-thalamic inhibition within a 
given nucleus or activate the inhibitory cells that comprise the reticular nucleus of the 
thalamus (Fanselow, 2012). It is thus possible that afferent trigeminal input arising from 
TNS could also evoke sufficient inhibition to interrupt any pathological oscillatory 
activity within the thalamus that could contribute to seizure activity (Fanselow, 2012). 
In this view, the alpha-activity oscillation in the awake brain, modulated by thalamo-
cortical firing and brainstem afferent inputs (Başar, 2012; Cooper et al., 2003), may act 
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as a seizure-preventing mechanism, inhibiting cortical abnormal excitability and ictal 
spreading. Indeed, the alpha-power enhancement seems to favour a talamo-cortical 
stabilization (Palva and Palva, 2007) similar to the “transient functional deafferentation” 
achieved during phases of stable synchronized Non-REM sleep (i.e. ‘closed thalamic 
gate’ theory) in which seizures are known to generally not occur (Gibbs et al., 2016).  
Moreover, some recent studies from intracranial EEG recording in epileptic patients 
demonstrated that the enhancement of alpha activity is able to modulate and temporally 
break ongoing gamma activity with a mechanism of regional pulsed inhibition (Jensen 
and Mazaheri, 2010; Osipova et al., 2008) and so attenuating the highly rhythmic 
components which have been found to often proceed epileptiform discharges 
(Medvedev, 2002; Fisher et al., 1992). 
These results are consistent with our findings which consider the alpha rhythm 
enhancement, during TNS stimulation, as a sign of cortical “functional inhibition”, 
generated by modulation of subcortical structures (Başar, 2012; Bazanova and Vernon, 
2014; Hughes and Crunelli, 2005). 
In keeping with the hypothesis of Diaz and co-workers (1998), a possible explanation of 
our results is that in patients with focal DRE, some unpredictable changes in the 
intrinsic dynamic properties of neural activity has led to a global reorganization across 
frequency power possibly with a lowering in alpha band, which may reflect a 
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dysfunction in thalamic–cortical circuits and eventually affect the cortical susceptibility 
to initiate seizures (Pyrzowski et al., 2015; Hughes and Crunelli, 2005; Klimesch et al., 
2007). 
In this substrate TNS could exert its effect by globally enhancing alpha power and so 
restoring the normal balance between excitatory and inhibitory mechanisms. 
This TNS effect has been documented only for the acute stimulus protocol in a relative 
small patient group, further TNS studies focused on the EEG chronic effect on epileptic 
subjects may be worthily performed in the perspective of shading new insights in the 











 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 





Aalbers M, Vles J, Klinkenberg S et al. Animal models for vagus nerve stimulation in 
epilepsy. Experimental Neurology 2011;230:167–175 
 
Amar AP, Levy ML, Apuzzoc MLJ. Vagus nerve stimulation for intractable epilepsy, in 
Neurosurgical Operative Atlas, S. Rengechary, Ed. Chicago, IL: American Association 
of Neurological Surgeons, 2000;9:179–188 
 
Aronica E, Gorter JA, Jansen GH, et al. Expression and cellular distribution of 
multidrug transporter proteins in two major causes of medically intractable epilepsy: 
focal cortical dysplasia and glioneuronal tumors. Neuroscience 2003;118:417-29 
  
Attenello F, Amar AP, Liu C et al. Slavin KV (ed): Stimulation of the Peripheral 
Nervous System. The Neuromodulation Frontier Prog Neurol Surg. Basel, Karger, 
2016, vol 29, pp 20–28  
 
Axelson HW, Isberg M, Flink R et al. Trigeminal Nerve Stimulation Does Not Acutely 
Affect Cortical Excitability in Healthy Subjects. Brain Stimulation 2014;7:613e617 
 
Bailey P, Bremer A. Sensory cortical representation of the vagus nerve: with a note on 
the effects of low blood pressure on the cortical electrogram. J Neurophysiol 
1938;1:405–412. 
 
Banzett RB, Guz A, Paydarfar D, et al. Cardiorespiratory variables and sensation during 
stimulation of the left vagus in patients with epilepsy. Epilepsy Res 1999;35:1–11  
 
Başar E. A review of alpha activity in integrative brain function: Fundamental 
physiology, sensory coding, cognition and pathology. Int J Psychophysiol 2012;86:1-24 
 
Bauer S, Baier H, Baumgartner C et al. Transcutaneous vagus nerve stimulation (tVNS) 
for treatment of drug resistant epilepsy: a randomized, double-blind clinical trial 
(cMPsE02). Brain Stimul 2016, doi:http://dx.doi.org/10.1016/j.brs.2015.11.003 
 
Bazanova OM, Vernon D. Interpreting EEG alpha activity. Neurosci Biobehav Rev 
2014;44:94-110 
 
Beekwilder JP, Beems T. Overview of the Clinical Applications of Vagus Nerve 
Stimulation. J Clin Neurophysiol 2010;27: 130–138 
 
Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: 
an estimate from population-based clinical and survey data. Epilepsia 2000;41:342–351 
 
Bell GS, Gaitatzis A, Bell CL, et al. Drowning in people with epilepsy: How great is the 
risk? Neurology 2008;71:578 
 
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Ben-Menachem E, Hamberger A, Hedner T et al. Effects of vagus nerve stimulation on 
amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy 
Res 1995;20:221–227 
 
Ben-Menachem E, Hellström K, Waldton C et al. Evaluation of refractory epilepsy 
treated with vagus nerve stimulation for up to 5 years. Neurology 1999;52: 1265–67 
 
Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet 
Neurology 2002;1:477–82 
 
Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-
invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J 
Neurol 2015;22:1260-8 
 
Berg AT, Levy SR, Novotny EJ et al. Predictors of intractable epilepsy in childhood: a 
case–control study. Epilepsia 1996;37:24–30 
 
Berg AT, Shinnar S, Levy SR et al. Early development of intractable epilepsy in 
children: a prospective study. Neurology 2001;56:1445–1452 
 
Berg AT, Vickrey BG, Testa FM, et al. How long does it take epilepsy to become 
intractable? A prospective investigation. Ann Neurol 2006;60:73 
 
Bodin C, Aubert S, Daquin G. Responders to vagus nerve stimulation (VNS) in 
refractory epilepsy have reduced interictal cortical synchronicity on scalp EEG. 
Epilepsy Res 2015;113:98-103 
 
Briggs DE, French JA. What makes epilepsy drug refractory? Expert Rev Neurother 
2003;3:127–31 
 
Camfield P, Camfield C. Nova Scotia pediatric epilepsy study. In: Jallon, P.; Berg, A.;  
Dulac, O., et al., editors. Prognosis of epilepsies. Montrouge France: John Libbey, 
Eurotext; 2003. p. 113 
 
Chae JH, Nahas Z, Lomarev M et al. A review of functional neuroimaging studies of 
vagus nerve stimulation (VNS). J Psychiatr Res 2003;37:443-55 
 
Chase MH, Nakamura Y, Clemente CD et al. Afferent vagal stimulation: neurographic 
correlates of induced EEG synchronization and desynchronization. Brain Res 
1967;5:236 –249 
 
Cheng G, Zhou X, Qu J et al. Central vagal sensory and motor connections: human 
embryonic and fetal development. Auton Neurosci 2004; 114: 83–96 
 
Cook IA, DeGiorgio CM, Miller PM et al. Noninvasive neuromodulation with 
trigeminal nerve stimulation: a novel treatment for major depressive disorder. Poster 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Cook IA, Schrader LM, Geist CL et al. Regional PET Activation with Trigeminal Nerve 
Stimulation in Major Depression. Boca Raton FL: NCDEU Annual Meeting; 2011 
 
Cook IA, Schrader LM, Degiorgio CM et al. Trigeminal nerve stimulation in major 
depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav 
2013;28:221–226 
 
Cook IA, Kealey CP, DeGiorgio CM. The potential use of trigeminal nerve stimulation 
in the treatment of epilepsy. Ther Deliv 2015;6:273–275 
 
Cooper NR, Croft RJ, Dominey SJ et al. Paradox lost? Exploring the role of alpha 
oscillations during externally vs. internally directed attention and the implications for 
idling and inhibition hypotheses. Int. J. Psychophysiol 2003;47:65–74 
 
Cross JH, Jaykar P, Nordli D, et al. Proposed criteria for referral and evaluation of 
children for epilepsy surgery: Recommendations of the Subcomission for Pediatric 
Epilepsy Surgery. Epilepsia 2006;47:953 
 
Cyberonics, Inc. (2012) VNS therapy products manuals and safety alerts: part I—
introduction—indications, warnings, and precautions, pp 7–13. 
http://dynamic.cyberonics.com/manuals/. Accessed 1 Oct 2012 
 
Dalkilic EB. Neurostimulation Devices Used in Treatment of Epilepsy. Curr Treat 
Options Neurol 2017;19:7 
 
De Ferrari GM, Crijns HJ, Borggrefe M et al. CardioFit Multicenter Trial Investigators. 
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic 
heart failure. Eur Heart J 2011;32: 847–55  
 
de Tisi J, Bell GS, Peacock JL, et al. The long-term outcome of adult epilepsy surgery, 
patterns of seizure remission, and relapse: a cohort study. Lancet 2011;378:1388–95 
 
DeGiorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus 
nerve stimulation for the treatment of refractory seizures. Epilepsia 2000; 41: 1195–
2000 
 
DeGiorgio MC, Shewmon A, Whitehurst T. Trigeminal nerve stimulation for epilepsy. 
Neurology 2003;61;421-422 
 
DeGiorgio CM, Shewmon A, Murray D et al. Pilot Study of Trigeminal Nerve 
Stimulation (TNS) for Epilepsy: A Proof-of-Concept Trial. Epilepsia 2006;47:1213–
1215 
 
DeGiorgio CM, Murray D, Markovic D et al. Trigeminal nerve stimulation for epilepsy: 
long-term feasibility and efficacy. Neurology 2009;72:936–938 
 
DeGiorgio CM, Fanselow EE, Schrader LM et al. Trigeminal nerve stimulation: 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
DeGiorgio CM, Soss J, Cook IA et al. Randomized controlled trial of trigeminal nerve 
stimulation for drug-resistant epilepsy. Neurology 2013a;80:786–791 
 
DeGiorgio CM and Krahl SE. Neurostimulation for Drug-Resistant Epilepsy. 
Continuum (Minneap Minn) 2013b;19:743–755 
 
Diaz GF, Virues T, San Martin M et al. Generalized background qEEG abnormalities in 
localized symptomatic epilepsy. Electroencephalogr Clin Neurophysiol 1998;106:501–
507 
 
Ekmekçi H, Kaptan H. Vagus Nerve Stimulation. Open Access Maced J Med Sci 
2017;5:391-394 
 
Elwes RD, Johnson AL, Shorvon SD et al. The prognosis for seizure control in newly 
diagnosed epilepsy. N Engl J Med 1984;311:944–947 
 
Englot DJ, Han SJ, Lawton MT et al. Predictors of seizure freedom in the surgical 
treatment of supratentorial cavernous malformations. J Neurosurg. 2011;115:1169-1174 
 
Englot DJ, Rolston JD,Wright CW et al. Rates and Predictors of Seizure Freedom With 
Vagus Nerve Stimulation for Intractable Epilepsy. Neurosurgery 2016;79:345–353 
 
Fang M, Xi ZQ, Wu Y et al. A new hypothesis of drug refractory epilepsy: neural 
network hypothesis. Med Hypotheses 2011;76:871–6 
 
Fanselow EE, Noel D. Reduction of neocortical neuronal firing by therapeutic 
trigeminal nerve stimulation. San Antonio, US; 2010. p. Abst. 2.220 
 
Fanselow EE, Reid AP, Nicolelis MA. Reduction of pentylenetetrazolinduced seizure 
activity in awake rats by seizure-triggered trigeminal nerve stimulation. J Neurosci 
2000;20:8160–8168 
 
Fanselow EE. Central mechanisms of cranial nerve stimulation for epilepsy. Surg 
Neurol Int 2012;3:S247-54 
 
Fisher RS, Webber WR, Lesser RP et al. High-frequency EEG activity at the start of 
seizures. J Clin Neurophysiol 1992;9:441–448 
 
Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: 
definitions proposed by the International League Against Epilepsy (ILAE) and the 
International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470–472 
 
Fisher RS, Acevedo C, Arzimanoglou A et al. A practical clinical definition of epilepsy. 
Epilepsia 2014;55:475–482 
 
Fois C, Kovac S, Khalil A et al. Predictors for being offered epilepsy surgery: 5-year 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Foley JO, DuBois F. Quantitative studies of the vagus nerve in the cat: I, the ratio of 
sensory to motor fibers. J Comp Neurol 1937;67: 49–97 
 
Fornai F, Ruffoli R, Giorgi SF et al. The role of locus coeruleus in the antiepileptic 
activity induced by vagus nerve stimulation. European Journal of Neuroscience 
2011;33:2169–2178 
 
Fountain NB, Van Ness PC, Bennett A, et al. Quality improvement in neurology: 
epilepsy update quality measurement set. Neurology 2015;84:1483–1487 
 
Fraschini M, Puligheddu M, Demuru M et al. VNS induced desynchronization in 
gamma bands correlates with positive clinical outcome in temporal lobe 
pharmacoresistant epilepsy. Neurosci Lett 2013;536:14–18 
 
Fraschini M, Demuru M, Puligheddu M et al. The re-organization of functional brain 
networks in pharmaco-resistant epileptic patients who respond to VNS. Neuroscience 
Letters 2014;580:153–157 
 
Fritsch B, Stott JJ, Donofrio JJ et al. Treatment of early and late kainic acid-induced 
status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. 
Epilepsia 2010;51:108–117 
 
Gelety TJ, Burgess RJ, Drake ME et al. Computerized spectral analysis of the interictal 
EEG in epilepsy. Clinical Electroencephalography 1985;16: 94–97 
 
Ghia JE, Blennerhassett P, Kumar-Ondiveeran H et al. The vagus nerve: a tonic 
inhibitory influence associated with inflammatory bowel disease in a murine model. 
Gastroenterology 2006;131:1122–30  
 
Gibbs SA, Proserpio P, Terzaghi M et al. Sleep-related epileptic behaviors and non-
REM-related parasomnias: Insights from stereo-EEG. Sleep Med Rev 2016;25:4-20 
 
Ginatempo F, Pirina P, Melis F et al. Short-term trigeminal neuromodulation does not 
alter sleep latency in healthy subjects: a pilot study. Neurol Sci 2017 Sep 30. doi: 
10.1007/s10072-017-3134-z. 
 
Goldman RI, Stern JM, Engel J Jr et al. Simultaneous EEG and fMRI of the alpha 
rhythm. Neuroreport 2002;13:2487-92 
 
Groves DA, Bowman EM, Brown VJ. Recordings from the rat locus coeruleus during 
acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 2005;379:174-9 
 
Haegens S. et al. a-Oscillations in the monkey sensorimotor network influence 
discrimination performance by rhythmical inhibition of neuronal spiking. Proc. Natl. 
Acad. Sci. U.S.A. 2011;108,19377–19382 
 
Hallbook T, Lundgren J, Blennow G et al. Long term effects on epileptiform activity 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Hammond EJ, Uthman BM, Reid SA et al. Electrophysiological studies of cervical 
vagus nerve stimulation in humans: I. EEG effects. Epilepsia 1992;33:1013–20 
 
Handforth A, DeGiorgio CM, Schachter SC et al. Vagus nerve stimulation therapy for 
partial-onset seizures: a randomized active-control trial. Neurology 1998; 51: 48–55 
 
Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy, and 
device parameters: scientific basis and recommendations for use. Neurology 
2002;59:S31–7 
 
Henry TR, Votaw JR, Pennell PB et al. Acute blood flow changes and efficacy of vagus 
nerve stimulation in partial epilepsy. Neurology 1999;52:1166–1173. 
 
Henry TR, Bakay RA, Pennell PB, Epstein CM, Votaw JR. Brain blood-flow alterations 
induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects 
at high and low levels of stimulation. Epilepsia 2004;45:1064-70 
 
Hermann BP, Seidenberg M, Dow C et al. Cognitive prognosis in chronic temporal lobe 
epilepsy. Ann Neurol 2006;60:80–87 
 
Hitiris N, Mohanraj R, Norrie J et al. Predictors of pharmacoresistant epilepsy. Epilepsy 
Res 2007;75:192–196 
 
Hughes SW and Crunelli V. Thalamic Mechanisms of EEG Alpha Rhythms and Their 
Pathological Implications. Neuroscientist 2005;11:357-72 
 
Jacoby A, Baker GA. Quality-of-life trajectories in epilepsy: a review of the literature. 
Epilepsy Behav 2008;12:557–571 
 
Jandova K, Pasler D, Antonio LL et al. Carbamazepine-resistance in the epileptic 
dentate gyrus of human hippocampal slices. Brain 2006;129:3290–3306  
 
Jaseja H. EEG-desynchronization as the major mechanism of anti-epileptic action of 
vagal nerve stimulation in patients with intractable seizures: Clinical neurophysiological 
evidence. Med Hypotheses 2010;74:855–856 
 
Jensen O, Mazaheri A. Shaping functional architecture by oscillatory alpha activity: 
gating by inhibition. Front Hum Neurosci 2010;186:1-8 
 
Joshi S, Kapur J. (2012) GABAA receptor plasticity during status epilepticus. In 
Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (Eds) Jasper’s 
basic mechanisms of the epilepsies [Internet]. 4th ed. National Center for Biotechnology 
Information (US), Bethesda, MD. Available at: http://www.ncbi.nlm. 
nih.gov/books/NBK98149/. 
 
Klimesch W, Sauseng P, Hanslmayr S. EEG alpha oscillations: theinhibition–timing 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Ko TS, Holmes GL. EEG and clinical predictors of medically intractable childhood 
epilepsy. Clin Neurophysiol 1999; 110: 1245–1251 
 
Koo B. EEG Changes With Vagus Nerve Stimulation. Journal of Clinical 
Neurophysiology 2001; 18:434 –441 
 
Kobau R, Zahran H, Thurman DJ et al. Epilepsy surveillance among adults: 19 states. 
MMWR Surveill Summ 2008;57:1–20 
 
Krahl SE, Clark KB, Smith DC et al. Locus coeruleus lesions suppress the seizure-
attenuating effects of vagus nerve stimulation. Epilepsia 1998;39:709–714 
 
Krahl SE, Senanayake SS, Handforth A. Destruction of peripheral C-fibers does not 
alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 
2001;42, 586–589 
 
Krahl SE, Clark KB. Vagus nerve stimulation for epilepsy: A review of central 
mechanisms. Surg Neurol Int 2012;3:S255-9 
 
Krishna V, Sammartino F, Kon Kam King N et al. Neuromodulation for Epilepsy. 
Neurosurg Clin N Am 2016;27:123-31 
 
Krout KE, Belzer RE, Loewy AD. Brainstem projections to midline and intralaminar 
thalamic nuclei of the rat. J Comp Neurol 2002;448:53-101 
 
Kuba R, Guzaninová M, Brázdil M et al. Effect of Vagal Nerve Stimulation on 
Interictal Epileptiform Discharges: A Scalp EEG Study. Epilepsia 2002;43:1181–1188 
 
Kuba R, Nesvadba D, Brazdil M et al. Effect of chronic vagal nerve stimulation on 
interictal epileptiform discharges. Seizure 2010;19:352–355  
 
Kwan P, Brodie MJ. Early Identification of refractory epilepsy. New England Journal of 
Medicine 2000;343:314–319 
 
Kwan P, Brodie MJ. Refractory epilepsy: mechanisms and solutions. Expert Rev 
Neurother 2006;6:397–406 
 
Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: 
consensus proposal by the ad hoc Task Force of the ILAE Commission on therapeutic 
strategies. Epilepsia 2010;51:1069–1077 
 
Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology 
2005;64:1131 
 
Lhatoo S, Sander J. The epidemiology of epilepsy and learning disablility. Epilepsia 
2001;42:6 
 
Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to 
antiepileptic drugs. J Pharmacol Exp Ther 2002;301:7–14 
75 
 
 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Lotvall J, Lunde H, Augustinson LE et al. Airway effects of direct left-sided cervical 
vagal stimulation in patients with complex partial seizures. Epilepsy Res 1994;18:149–
54 
 
Loup F, Wieser HG, Yonekawa Y et al. Selective alterations in GABAA receptor 
subtypes in human temporal lobe epilepsy. J Neurosci 2000;20:5401–19 
 
Magnes J, Moruzzi G, Pompeino O. Synchronization of the EEG produced by low 
frequency stimulation of the region of the solitary tract. Arch Ital Biol 1961;99:33–67. 
 
Mao Q, Unadkat JD. Role of the breast cancer resistance protein (BCRP/ ABCG2) in 
drug transport – an update. AAPS J 2015;17:65–82 
 
Marrosu F, Santoni F, Puligheddu M et al. Increase in 20–50 Hz (gamma frequencies) 
power spectrum and synchronization after chronic vagal nerve stimulation. Clinical 
Neurophysiology 2005;116:2026–2036 
 
McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus 
nerve. Epilepsia 1993;34:918–23 
 
Medvedev AV. Epileptiform spikes desynchronize and diminish fast (gamma) activity 
of the brain An “anti-binding” mechanism? Brain Res Bull 2002;58:115-28 
 
Mercante B, Pilurzi G, Ginatempo F et al. Trigeminal nerve stimulation modulates 
brainstem more than cortical excitability in healthy humans. Exp Brain Res 
2015;233:3301-11 
 
Mercante B, Enrico P, Floris G et al. Trigeminal nerve stimulation induces Fos 
immunoreactivity in selected brain regions, increases hippocampal cell proliferation and 
reduces seizure severity in rats. Neuroscience 2017;361:69-80 
 
Mohamed IS, Minassian BA: What intractability information is there in the type of 
generalized seizure? Adv Neurol 2006;97:141–147 
 
Mohanraj R, Brodie MJ. Early predictors of outcome in newly diagnosed epilepsy. 
Seizure 2013;22:333–44 
 
Morris GL, Mueller WM, and the Vagus Nerve Stimulation Study Group EO1–EO5. 
Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. 
Neurology 1999; 53: 1731–35 
 
Morris GL, Gloss D, Buchhalter J et al. Evidence- based guideline update: vagus nerve 
stimulation for the treatment of epilepsy: Report of the Guideline Development 
Subcommittee of the American Academy of Neurology. Neurology 2013;81:1453-1459 
 
Moruzzi G, Magoun HW. Brainstem reticular formation and activation of the EEG. 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Moseley BD, Degiorgio CM. Refractory status epilepticus treated with trigeminal nerve 
stimulation. Epilepsy Res 2014;108:600–603 
 
Murray CJL, Lopez AD, eds. Global Comparative Assessment in the Health Sector; 
Disease Burden, Expenditures, and Intervention Packages. Geneva: World Health 
Organization; 1994 
 
Murray CJL, Vos T, Lozano R et al. Disability adjusted life years (DALYs) for 291 
diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global 
Burden of Disease Study 2010. Lancet 2012;380:2197–2223 
 
Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos immunoreactivity in the 
brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 1995;22:53–62 
 
Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of 
childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008;7:500-6 
 
Nune G, DeGiorgio C, Heck C. Neuromodulation in the Treatment of Epilepsy. Curr 
Treat Options Neurol 2015;17:43 
 
Osharina V, Bagaev V, Wallois F et al. Autonomic response and Fos expression in the 
NTS following intermittent vagal stimulation: Importance of pulse frequency. Auton 
Neurosci 2006;126-127:72-80 
 
Osipova D, Hermes D, and Jensen O. Gamma power is phase locked to posterior alpha 
activity. PLoSONE 2008;3, e3990. doi: 10.1371/journal. pone.0003990 
 
Oskoui M, Webster RI, Zhang X et al. Factors predictive of outcome in childhood 
epilepsy. J Child Neurol 2005;20:898–904 
 
Palva S and Palva JM. New vistas for a-frequency band oscillations. TRENDS Neurosci 
2007;30:150-158 
 
Panebianco M, Rigby A,Weston et al. Vagus nerve stimulation for partial seizures. 
Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD002896 
 
Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal 
stimulation in humans: preliminary results. Epilepsia 1990;31: S40–S43 
 
Pilurzi G, Mercante B, Ginatempo F et a. Transcutaneous trigeminal nerve stimulation 
induces a long-term depression-like plasticity of the human blink reflex. Exp Brain Res. 
2016;234:453-61 
 
Pompeiano O, Swett JE. EEG and behavioral manifestations of sleep  induced by 
cutaneous nerve stimulation in normal cats. Arch Ital Biol 1962;100:311-342 
 
Pop J, Murray D, Markovic D et al. Acute and long-term safety of external trigeminal 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Pyrzowski J, Siemiński M, Sarnowska A et al. Interval analysis of interictal EEG: 
pathology of the alpha rhythm in focal epilepsy. Sci. Rep. 2015;5:16230 
 
Randall WC, Ardell JL. Differential innervation of the heart. In: Sipes D, Jalife J, eds. 
Cardiac electrophysiology and arrhythmias. New York: Grune and Stratton, 1985: 137–
44 
 
Ravan M, Sabesan S, D'Cruz ON. On Quantitative Biomarkers of VNS Therapy using 
EEG and ECG Signals, IEEE. Trans Biomed Eng 2017a;64:419–428 
 
Ravan M. Investigating the correlation between short-term effectiveness of VNS 
Therapy in reducing the severity of seizures and long-term responsiveness. Epilepsy 
Research 2017b http://dx.doi.org/10.1016/j.eplepsyres.2017.04.008 
 
Remy S, Gabriel S, Urban BW et al. A novel mechanism underlying drug resistance in 
chronic epilepsy. Ann Neurol 2003;53:469–79 
 
Remy S, Beck H. Molecular and cellular mechanisms of pharmacoresistance in 
epilepsy. Brain 2006;129:18–35 
 
Ring HA, White S, Costa DC et al. A SPECT study of the effect of vagal nerve 
stimulation on thalamic activity in patients with epilepsy. Seizure 2000;9:380-4 
 
Rizzo P, Beelkea M, De Carli F et al. Modifications of sleep EEG induced by chronic 
vagus nerve stimulation in patients affected by refractory epilepsy. Clin Neurophysiol 
2004;115:658–664 
 
Rocha L. Interaction between electrical modulation of the brain and pharmacotherapy to 
control pharmacoresistant epilepsy. Pharmacol Ther 2013;130:211-28 
 
Rogawski MA, Johnson MR. Intrinsic severity as a determinant of antiepileptic drug 
refractoriness. Epilepsy Curr 2008;8:127–130 
 
Rogawski MA. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic 
drugs. Epilepsia 2013;54:33–40 
 
Roosevelt RW, Smith DC, Clough RW et al. Increased extracellular concentrations of 
norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. 
Brain Res 2006;1119:124-32 
 
Ruffoli R, Giorgi FS, Pizzanelli C et al. The chemical neuroanatomy of vagus nerve 
stimulation. J Chem Neuroanat 2011;42(4): 288-296 
 
Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of 
vagus nerve stimulation. Epilepsia 1990;31:S1–S6 
 
Salinsky MC and Burchiel KJ. Vagus Nerve Stimulation Has No Effect on Awake EEG 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Santiago-Rodríguez E, Alonso-Vanegas M, Cárdenas-Morales L et al. Effects of two 
different cycles of vagus nerve stimulation on interictal epileptiform discharges. Seizure 
2006;15:615-20 
 
Schiller Y, Najjar Y: Quantifying the response to antiepileptic drugs: effect of past 
treatment history. Neurology 2008;70:54–65 
 
Schoenen J, Vandersmissen B, Jeangette S et al. Migraine prevention with a 
supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology 
2013;80:697–704 
 
Schrader LM, Geist CL, DeGiorgio CM, et al. Regional PET activations with trigeminal 
nerve stimulation (TNS) and correlation with therapeutic response. Epilepsy Curr 
2012;12:235-6 
 
Schulze-Bonhage A. Brain stimulation as a neuromodulatory epilepsy therapy. Seizure 
2017;44:169–175 
 
Semah F, Picot MC, Adam C et al. Is the underlying cause of epilepsy a major 
prognostic factor for recurrence? Neurology 1998; 51: 1256-62 
 
Sheth GS, Krauss G, Krumholz A et al. Mortality in epilepsy: driving fatalities vs other 
causes of death in patients with epilepsy. Neurology 2004;63:1002 
 
Shiozawa P, da Silva ME, de CarvalhoTC et al. Transcutaneous vagus and trigeminal 
nerve stimulation for neuropsychiatric disorders: a systematic review. Arq 
Neuropsiquiatr 2014;72:542-547 
 
Shiozawa P, da Silva ME, Netto GT et al. Effect of a 10-day trigeminal nerve 
stimulation (TNS) protocol for treating major depressive disorder: a phase II, sham-
controlled, randomized clinical trial. Epilepsy Behav 2015;44:23-6. doi: 
10.1016/j.yebeh.2014.12.024. 
 
Shiozawa P. Electroencephalographic changes following a trigeminal nerve stimulation 
(TNS) protocol: Assessing a novel depression treatment. Epilepsy & Behavior 
2016;58:141–142 
 
Sillanpaa M. Remission of seizures and predictors of intractability in long-term follow-
up. Epilepsia 1993; 34: 930-6 
 
Sillanpaa M, Jalava M, Shinnar S. Epilepsy syndromes in patients with childhood-onset 
seizures in Finland. Pediatr Neurol 1999;21:533–537 
 
Sillanpaa M, Schmidt D. Early seizure frequency and aetiology predict long-term 
medical outcome in childhood-onset epilepsy. Brain 2009;132:989–998 
 
Silverman DH, Geist CL, Cook I et al. Effects on regional cerebral blood flow of 




 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Sisodiya SM, Lin WR, Harding BN et al. Drug resistance in epilepsy: expression of 
drug resistance proteins in common causes of refractory epilepsy. Brain 2002;125:22-31 
 
Sisodiya SM, Martinian L, Scheffer GL et al. Vascular colocalization of P-glycoprotein, 
multidrug- resistance associated protein 1, breast cancer resistance protein and major 
vault protein in human epileptogenic pathologies. Neuropathol Appl Neurobiol 
2006;32:51–63 
 
Soss J, Heck C, Murray D et al. A prospective long-term study of external trigeminal 
nerve stimulation for drug-resistant epilepsy. Epilepsy & Behavior 2015;42:44–47 
 
Specchio LM, Beghi E. Should antiepileptic drugs be withdrawn in seizure-free 
patients? CNS Drugs 2004;18:201– 212 
 
Sperling MR, Barshow S, Nei M et al. A reappraisal of mortality after epilepsy surgery. 
Neurology 2016;86:1938–1944 
 
Steriade M, Glenn LL. Neocortical and caudate projections of intralaminar thalamic 
neurons and their synaptic excitation from midbrain reticular core. J Neurophysiol 
1982;48:352-71 
 
Strozzi I, Nolan SJ, Sperling MR et al. Early versus late antiepileptic drug withdrawal 
for people with epilepsy in remission. Cochrane Database of Systematic Reviews 2015, 
Issue 2. Art. No.: CD001902. DOI:10.1002/14651858.CD001902.pub2 
 
Tang F, Hartz AMS, Bauer B. Drug-Resistant epilepsy: Multiple Hypotheses, Few 
Answers. Front Neurol 2017;8:301. doi: 10.3389/fneur.2017.00301 
 
Tate SK, Depondt C, Sisodiya SM et al. Genetic predictors of the maximum doses 
patients receive during clinical use of the anti-epileptic drugs carbamazepine and 
phenytoin. Proc Natl Acad Sci USA 2005; 102: 5507–5512 
 
The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic 
vagus nerve stimulation for the treatment of medically intractable seizures. Neurology 
1995;45:224–30 
 
Tishler DM, Weinberg KI, Hinton DR et al. MDR1 gene expression in brain of patients 
with medically intractable epilepsy. Epilepsia 1995;36:1–6 
 
van der Werf YD, Witter MP, Groenewegen HJ. The intralaminar and midline nuclei of 
the thalamus. Anatomical and functional evidence for participation in processes of 
arousal and awareness. Brain Res Brain Res Rev 2002;39:107-40 
 
VanRullen R, Koch C. Competition and selection during visual processing of natural 
scenes and objects. J. Vis. 2003;3, 75–85 
 
Walczak TS, Leppik IE, D’Amelio M, et al. Incidence and risk factors in sudden 
unexpected death in epilepsy: a prospective cohort study. Neurology 2001;56:519 
80 
 
 Dott.ssa Chiara Fois. Peripheral neuromodulation for drug-resistant epilepsy: the effect of short-term transcutaneous trigeminal nerve stimulation on 
EEG activity. Tesi di Dottorato in Neuroscienze, Corso di Dottorato in Scienze Biomediche. Università degli Studi di Sassari.   
 
Walker BR, Easton A, Gale K. Regulation of limbic motor seizuresnby GABA and 
glutamate transmission in nucleus tractus solitarius. Epilepsia 1999;40:1051–1057 
 
Wang H, Chen X, Lin Z et al. Long-term effect of vagus nerve stimulation on interictal 
epileptiform discharges in refractory epilepsy. Journal of the Neurological Sciences 
2009;284:96–102 
 
Wang Q, Zhu L, Wang X et al. Chronic Trigeminal Nerve Stimulation Protects Against 
Seizures, Cognitive Impairments, Hippocampal Apoptosis, and Inflammatory 
Responses in Epileptic Rats. J Mol Neurosci 2016;59:78–89 
 
Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus 
and its treatment with new antiepileptic drugs. Epilepsia 2008;49:63–73 
 
World Health Organization. Atlas: Epilepsy Care in the World. Geneva: World Health 
Organization; 2005:91 
 
Yuan H, Silberstein SD. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive 
Review: Part III. Headache 2016;56:479-490 
 
Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. 
Epilepsia 1992;33:1005-12 
 
Zanchetti A, Wang SC, Moruzzi G. The effect of vagal afferent stimulation on the EEG 
pattern of the cat. Electroencephalogr Clin Neurophysiol 1952;4:357 
 
Zare M, Salehi M, Mahvari J et al. Trigeminal nerve stimulation: A new way of 
treatment of refractory seizures. Adv Biomed Res 2014;3:81. 
 
 
 
 
 
